2026/05/10 更新

写真a

セキ トモヒサ
関 倫久
Seki Tomohisa
所属
医歯薬学域 教授
職名
教授
外部リンク

学位

  • 博士(医学) ( 2011年3月   慶應義塾大学 )

研究キーワード

  • 医療リアルワールドデータ

  • 予測モデル

  • 大規模言語モデル

  • 機械学習

  • AIの公平性

学歴

  • 慶應義塾大学   School of Medicine   Doctorate of Medical Science

    2008年 - 2011年

      詳細を見る

  • 慶應義塾大学   School of Medicine  

    2000年 - 2006年

      詳細を見る

経歴

  • 岡山大学   学術研究院医歯薬学域 医療情報応用学分野   教授

    2026年4月 - 現在

      詳細を見る

  • 東京大学医学部附属病院   企画情報運営部   特任助教

    2026年4月 - 現在

      詳細を見る

  • 東京大学医学部附属病院   企画情報運営部   助教

    2019年4月 - 2026年3月

      詳細を見る

  • 東京大学医学部附属病院   企画情報運営部   特任研究員

    2018年 - 2019年

      詳細を見る

  • 慶應義塾大学医学部   救急医学教室   助教

    2014年 - 2018年

      詳細を見る

  • 慶應義塾大学医学部   循環器内科学教室   助教

    2014年

      詳細を見る

  • 日本学術振興会   日本学術振興会特別研究員

    2011年 - 2014年

      詳細を見る

  • 栃木県済生会宇都宮病院   初期臨床研修医

    2006年 - 2008年

      詳細を見る

▼全件表示

所属学協会

 

論文

  • Machine Learning Models Incorporating Nursing Care Needs to Predict 180-Day Prognosis in Patients With Heart Failure ― Validation With Discrimination and Calibration Analyses ―

    Takuya Nishino, Katsuhito Kato, Shuhei Tara, Daisuke Hayashi, Tomohisa Seki, Toru Takiguchi, Yoshiaki Kubota, Takeshi Yamamoto, Mitsunori Maruyama, Eitaro Kodani, Nobuaki Kobayashi, Akihiro Shirakabe, Toshiaki Otsuka, Shoji Yokobori, Yukihiro Kondo, Kuniya Asai

    CIRCULATION REPORTS   2026年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1253/circrep.CR-25-0337

    Web of Science

    researchmap

  • High-Fidelity Longitudinal Patient Simulation Using Real-World Data

    Yu Akagi, Tomohisa Seki, Hiromasa Ito, Toru Takiguchi, Kazuhiko Ohe, Yoshimasa Kawazoe

    arXiv.2601.17310   2026年1月

     詳細を見る

  • Natural Language Processing-Based Visualization Framework for Adverse Events Extracted from Clinical Narratives: Towards Enhancing Clinical Interpretability.

    Masami Tsuchiya, Yoshimasa Kawazoe, Kiminori Shimamoto, Tomohisa Seki, Yuki Yanagisawa, Shungo Imai, Hayato Kizaki, Emiko Shinohara, Shuntaro Yada, Tomohiro Nishiyama, Shoko Wakamiya, Eiji Aramaki, Satoko Hori

    Biological & pharmaceutical bulletin   49 ( 3 )   473 - 479   2026年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Subjective adverse events (AEs), such as pain, are often under-recognized when relying solely on structured data. Although natural language processing (NLP) enables the extraction of AEs from narrative electronic health records (EHRs), interpretation of their temporal dynamics is difficult. Visualization methods can bridge this gap by transforming text-derived symptom data into clinically interpretable data. This study aimed to demonstrate the clinical value of a framework integrating NLP-based AE extraction with time-series visualization for otherwise invisible symptoms. Narrative texts, including progress notes, nursing records, and discharge summaries, were processed using MedNERN-CR-JA, a pretrained Japanese BERT-based model for entity recognition. AEs were visualized using Kaplan-Meier curves to represent the time to first onset and heatmaps, displaying all subsequent symptom documentation alongside supportive medication use. Among the 35042 eligible patients, 3094 received paclitaxel (PTX) and were matched to 3094 controls. PTX was associated with a higher risk of musculoskeletal symptoms (hazard ratio, 1.77; 95% confidence interval: 1.57-1.99). Kaplan-Meier curves showed earlier onset in PTX recipients, while heatmaps depicted recurrent documentation and the corresponding analgesic use. Restricting the analyses to the triweekly PTX regimen reduced the heterogeneity between inpatient and outpatient documentation and revealed a clearer alignment between the treatment cycles and acute symptom onset. This framework demonstrates the clinical value of visualizing NLP-extracted AEs from narrative EHRs, improving the resolution of subjective AE data, enhancing monitoring, and supporting patient-centered care and clinical decision making through complementary time-to-event and heatmap visualizations.

    DOI: 10.1248/bpb.b25-00609

    PubMed

    researchmap

  • A scalable natural language processing framework for drug repurposing in chemotherapy-induced adverse events from clinical narrative records. 国際誌

    Masami Tsuchiya, Mari Inoue, Yoshimasa Kawazoe, Kiminori Shimamoto, Tomohisa Seki, Shungo Imai, Hayato Kizaki, Emiko Shinohara, Shuntaro Yada, Shoko Wakamiya, Eiji Aramaki, Satoko Hori

    European journal of cancer (Oxford, England : 1990)   232   116157 - 116157   2025年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Preventing chemotherapy-related adverse events (AEs) remains an unmet clinical challenge. Preclinical studies have suggested protective effects of several existing agents, but translation into human evidence has been limited. We aimed to establish proof of concept (PoC) for drug repurposing by applying a natural language processing (NLP)-based framework to electronic health record (EHR) narratives, thereby bridging preclinical findings with clinical validation. METHODS: We retrospectively analyzed 56,326 patients with cancer treated at the University of Tokyo Hospital (2004-2023). A transformer-based NLP model extracted symptomatic AEs from clinical notes. Candidate preventive drugs identified from preclinical evidence were assessed using propensity score matching and Cox proportional hazards models. We evaluated angiotensin II receptor blockers (ARBs) for fluoropyrimidine-induced oral mucositis and ramelteon for platinum-induced peripheral neuropathy, with laxatives serving as a negative control. RESULTS: NLP demonstrated high accuracy (precision 0.81-0.83; recall 0.95-0.97). After matching, ARB co-administration was significantly associated with reduced mucositis incidence (hazard ratio [HR] 0.58, 95 % confidence interval [CI] 0.44-0.77; P < 0.001), representing a clinical PoC consistent with mechanistic preclinical data. Ramelteon showed an exploratory protective signal against neuropathy (HR 0.60, 95 % CI:0.38-0.93; P = 0.024). No preventive association was observed for laxatives. CONCLUSIONS: This study introduces a scalable NLP-epidemiology framework for non-invasive, real-world validation of drug repurposing candidates. The ARB finding provides human-level PoC evidence supporting prospective clinical testing, while the ramelteon signal warrants further exploration. Our approach demonstrates how EHR narratives can operationalize translational research, prioritizing safe, accessible agents for improving the tolerability of cancer treatment.

    DOI: 10.1016/j.ejca.2025.116157

    PubMed

    researchmap

  • Sex difference patterns in the association of low-density lipoprotein cholesterol with disease risk and all-cause mortality: A nationwide retrospective cohort study

    Tomohisa Seki, Toru Takiguchi, Yu Akagi, Hiromasa Ito, Kazumi Kubota, Kana Miyake, Masafumi Okada, Yoshimasa Kawazoe

    Journal of Clinical Lipidology   2025年11月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.jacl.2025.09.004

    researchmap

  • Evaluation of Synthetic Data Generation Methods for Medical Tabular Data: Representation of Distribution Tails. 国際誌

    Ohmi Mohri, Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    Studies in health technology and informatics   329   668 - 672   2025年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Synthetic data generation by Artificial Intelligence (AI) and other means has the potential to share and analyze data while preserving privacy and maintaining statistical characteristics, and various methods have been developed. In medical datasets, abnormal values are more critical than normal values for identifying diseases, making the accurate representation of distribution tails essential. However, existing evaluations of synthetic data generation methods often have not focused on distribution tails. This study generated synthetic data from actual specimen test results at a university hospital and analyzed the representation of distribution tails. As a result, we found that the Forest Diffusion model better represents the tails of distribution characteristics of the original data than the Gaussian Copula model or the Conditional generative adversarial networks (CTGAN) model. As distribution tails vary significantly across generation methods, careful consideration of tail characteristics is crucial when generating synthetic medical data.

    DOI: 10.3233/SHTI250924

    PubMed

    researchmap

  • Assessment of Medically Relevant Ageism Inherent in Large Language Models. 国際誌

    Tomohisa Seki, Yoshimasa Kawazoe, Hiromasa Ito, Toru Takiguchi, Yu Akagi, Memi Ebara, Kazuhiko Ohe

    Studies in health technology and informatics   329   603 - 607   2025年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    As the global population ages, the importance of reducing or eliminating social agism increases. However, although the medical field is known to be pervasive in terms of ageism against the older people, such assessments have not yet been conducted in terms of equity in large language models (LLMs). In this study, we created a dataset to assess the potential for medically related ageism among LLMs and attempted to visualize it. These results suggest that many LLMs exhibit stereotypical ageism in terms of reluctance to intervene in treatment and self-ageism. These results indicate the importance of developing a framework to avoid or reduce ageism in the social implementation of LLMs in the medical field.

    DOI: 10.3233/SHTI250911

    PubMed

    researchmap

  • Corpus-Based Evaluation of Decision-Making in Medical Ethics by Large Language Models. 国際誌

    Memi Ebara, Yoshimasa Kawazoe, Tomohisa Seki, Emiko Shinohara, Eisuke Nakazawa, Kazuhiko Ohe

    Studies in health technology and informatics   329   322 - 326   2025年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Assessing the ethical biases of large language models (LLMs) is crucial for their clinical application. To evaluate the ethical behavior of LLMs in clinical settings, we introduce a text corpus that focuses on ethical dilemmas. The corpus comprises 50 scenarios of clinical cases, each consisting of a clinical situation and options that impose ethical dilemmas. Each option is scored based on four ethical principles, enabling the evaluation of the ethical decision-making capabilities of LLMs based on their decision trajectories. The GPT-4 and GEMINI LLMs demonstrate significantly higher ethical scores than random selection across all ethical principles. Furthermore, both LLMs demonstrate adaptability to instructions for specific cases, revealing ethical vulnerabilities because they comply with ethically undesirable instructions. Future corpus expansion may allow evaluating diverse cultural and institutional contexts, thereby enhancing ethical evaluation.

    DOI: 10.3233/SHTI250854

    PubMed

    researchmap

  • Elucidating Celecoxib's Preventive Effect in Capecitabine-Induced Hand-Foot Syndrome Using Medical Natural Language Processing 国際誌

    Masami Tsuchiya, Yoshimasa Kawazoe, Kiminori Shimamoto, Tomohisa Seki, Shungo Imai, Hayato Kizaki, Emiko Shinohara, Shuntaro Yada, Shoko Wakamiya, Eiji Aramaki, Satoko Hori

    JCO Clinical Cancer Informatics   9   e2500096   2025年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PURPOSE: Capecitabine, an oral anticancer agent, frequently causes hand-foot syndrome (HFS), affecting patients' quality of life and treatment adherence. However, such symptomatic toxicities are often difficult to detect in structured electronic health record (EHR) data. This study primarily aimed to validate a natural language processing (NLP) approach to identifying capecitabine-induced HFS from unstructured clinical text and demonstrate its application in evaluating medication-associated adverse event trends in real-world settings. METHODS: We conducted a retrospective cohort study using EHRs from the University of Tokyo Hospital (2004-2021). HFS cases were identified using the MedNERN-CR-JA NLP model. After propensity score matching, we compared capecitabine users with and without celecoxib and assessed time to HFS onset using Cox proportional hazards models. NLP-based HFS detection was validated through manual annotation of aggregated clinical notes. Negative control and sensitivity analyses ensured robustness. RESULTS: Among 44,502 patients with cancer, 669 capecitabine users were analyzed. HFS incidence was significantly higher among capecitabine users (hazard ratio [HR], 1.93 [95% CI, 1.48 to 2.52]; P < .001) compared with nonusers. Celecoxib use showed a suggestive association with a reduced HFS risk (HR, 0.51 [95% CI, 0.24 to 1.07]; P = .073). The NLP model demonstrated high accuracy in identifying HFS, achieving a precision of 0.875, recall of 1.000, and F1 score of 0.933, based on manual annotation of patient-level clinical notes. Outcome trends remained consistent when using manually annotated HFS case labels instead of NLP-detected events, supporting the method's robustness. CONCLUSION: These findings demonstrate the effectiveness of NLP in detecting HFS from real-world clinical records. The application to celecoxib-HFS detection illustrates the potential utility of this approach for retrospective safety analysis. Further work is needed to evaluate generalizability across diverse clinical settings.

    DOI: 10.1200/CCI-25-00096

    PubMed

    researchmap

  • Transfusion ratios and survival in severe blunt trauma patients receiving massive transfusion. 国際誌

    Toru Takiguchi, Tomohisa Seki, Takashi Tagami, Yu Akagi, Ryuta Nakae, Hiromasa Ito, Yoshimasa Kawazoe, Ichiro Okada, Shiei Kim, Masaaki Inoue, Kazuhiko Ohe, Shoji Yokobori

    Scientific reports   15 ( 1 )   25519 - 25519   2025年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The optimal transfusion ratios for severe blunt trauma requiring massive transfusion remain unclear. This nationwide retrospective cohort study used data from the Japan Trauma Data Bank (2019-2022) and included patients receiving ≥ 10 units of packed red blood cells (pRBC) within 24 h. The fresh frozen plasma (FFP)-to-pRBC and platelet concentrate (PC)-to-pRBC ratios were categorized as 0-0.5, 0.5-1, 1-1.5, 1.5-2, and > 2. Among 2,849 eligible patients, an FFP-to-pRBC ratio of 1-1.5 was associated with significantly higher in-hospital survival than 0.5-1 (adjusted odds ratio [OR], 1.46; 95% confidence interval [CI], 1.12-1.92; P = 0.006). A PC-to-pRBC ratio of 1.5-2 also showed a trend toward improved survival (1.62; 1.00-2.69; P = 0.053). Patients were categorized into three phenotypes: truncal trauma with shock (70.3%), moderate head and extremity trauma (11.8%), and severe head trauma with consciousness disturbances (17.9%). In the truncal trauma with shock phenotype, FFP-to-pRBC ratios of 1-1.5 (1.56; 1.12-2.20; P = 0.010) and > 2 (2.32; 1.14-5.10; P = 0.027) were associated with improved survival. Higher FFP-to-pRBC and PC-to-pRBC ratios may be associated with improved survival, especially in truncal trauma with shock.

    DOI: 10.1038/s41598-025-11338-7

    PubMed

    researchmap

  • Development and validation of personalized risk prediction models for patients with IgA nephropathy: a nationwide multicenter cohort study. 国際誌

    Keita Hirano, Tatsuyoshi Ikenoue, Tomohisa Seki, Sho Komukai, Hirosuke Nakata, Takashi Yasuda, Yoshinari Yasuda, Keiichi Matsuzaki, Tetsuya Kawamura, Takashi Yokoo, Shoichi Maruyama, Hitoshi Suzuki, Yusuke Suzuki, Shingo Fukuma

    Journal of nephrology   2025年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Effective prediction of immunoglobulin A nephropathy (IgAN) progression is crucial for early intervention and management. We aimed to develop and validate distinct IgAN prediction models for clinical and research applications. METHODS: We analyzed data from the Japanese Nationwide Retrospective Cohort Study in IgAN (n = 1174) gathered over 10 years. The models were developed and tested using data from general physicians in primary care, specialists in tertiary care hospitals, and researchers at academic research institutes. Three tailored prediction models (Primary Care, Tertiary Care, and Research Institute Models) were created to address the unique needs of different clinical environments. The primary outcome was a composite renal event defined as a 1.5-fold increase in serum creatinine level or progression to kidney failure. The predictive performance was assessed using C-statistics. RESULTS: In the derivation cohort, the primary care model included predictors such as estimated glomerular filtration rate < 45 mL/min/1.73 m2, proteinuria ≥ 0.5 g/day, and non-use of corticosteroids, achieving a C-statistic of 0.796 (95% confidence interval [CI] 0.686-0.895). The tertiary care model showed a C-statistic of 0.807 (95% CI 0.713-0.886), using predictors such as glomerular number and histological severity. The research institute model, incorporating 38 variables, demonstrated a C-statistic of 0.802 (95% CI 0.686-0.906). CONCLUSIONS: The prediction models for primary and tertiary care settings provided effective tools for forecasting renal outcomes in IgAN patients and are competitive with more complex machine learning-based models used in research. These models can help guide clinical decisions in various healthcare settings.

    DOI: 10.1007/s40620-025-02338-x

    PubMed

    researchmap

  • Prognostic impact of the timing of antihypertensive medication initiation for hypertension detected at health screening on primary prevention of adverse cardiovascular events: Age-stratified real-world data analysis. 国際誌

    Hiromasa Ito, Tomohisa Seki, Yoshimasa Kawazoe, Toru Takiguchi, Yu Akagi, Kazumi Kubota, Kana Miyake, Masafumi Okada, Kazuhiko Ohe

    Hypertension research : official journal of the Japanese Society of Hypertension   2025年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The association between age and timing of antihypertensive treatment initiation and its effect on outcomes of patients with hypertension remain unclear. We investigated the impact of the time to antihypertensive therapy initiation for cardiovascular event primary prevention in an age-stratified analysis using data from a nationwide health claims database. This observational cohort study analyzed claim and health examination data recorded between January 1, 2005, and April 30, 2021, in the Japan Medical Data Center database. Patients with hypertension treated with antihypertensive agents were grouped by time (years) to therapy initiation: <1 (reference group), 1-2, and ≥2. The primary outcome was a composite outcome encompassing cardiovascular death, acute coronary syndrome, heart failure, and cerebrovascular disease. The secondary outcome was all-cause mortality. Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals adjusted for the time to treatment (TTI) group, age, male sex, systolic blood pressure, smoking status, dyslipidemia, diabetes, and visceral obesity. Among 520,669 participants, TTI ≥ 1 year conferred significantly higher hazard ratios for primary outcomes than TTI < 1 year in individuals aged ≥40 years. Hazard ratios (95% confidence intervals) for the primary outcome with TTI of 1-2 and >2 years were 1.215 (1.073-1.375) and 1.296 (1.163-1.444) in those aged 40-49 years and 1.268 (1.144-1.406) and 1.341 (1.224-1.468) in those aged 50-59 years, respectively. TTI ≥ 2 years was an independent prognostic factor for the secondary outcome of all-cause mortality in those aged ≥40 years.

    DOI: 10.1038/s41440-025-02249-1

    PubMed

    researchmap

  • A Generative Foundation Model for Structured Patient Trajectory Data. 国際誌

    Yu Akagi, Tomohisa Seki, Yoshimasa Kawazoe, Toru Takiguchi, Kazuhiko Ohe

    AMIA ... Annual Symposium proceedings. AMIA Symposium   2024   124 - 133   2025年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Advancements in artificial intelligence propelled the implementation of general-purpose multitasking agents called foundation models. However, it has been challenging for foundation models to handle structured longitudinal medical data due to the mixed data types and variable timestamps in these data. Acquiring large training data is another obstacle. This study proposes a generative foundation model to manage patient trajectory data of variable lengths with mixed data types (categorical and continuous variables). Additionally, we propose a data pipeline to supply real-world data large enough to support foundation models. We locally obtained a large clinical dataset with a reproducible data pipeline scheme that leveraged a national HL7 message standard. Our trained model acquired the ability to suggest clinically relevant medical concepts and continuous variables for general purposes. The model also synthesized a database of more than 10,000 realistic patient trajectories. Our results suggest promising future downstream clinical applications of the foundation model.

    PubMed

    researchmap

  • Evaluation of Perioperative Cardiovascular Event Risk in Gastrointestinal Surgery - Predictive Modeling and Risk Stratification Using Machine Learning.

    Hiromasa Ito, Tomohisa Seki, Yoshimasa Kawazoe, Toru Takiguchi, Yu Akagi, Kazumi Kubota, Kana Miyake, Masafumi Okada, Kazuhiko Ohe

    Circulation journal : official journal of the Japanese Circulation Society   2025年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Preoperative risk assessment is very important to ensure surgical safety and predict postoperative complications. However, no large-scale studies have evaluated the risk of perioperative cardiovascular events in Japan. This study evaluated perioperative cardiovascular events using real-world data. In addition, the applicability of machine learning to risk stratification was examined to develop a predictive model for perioperative cardiovascular events. METHODS AND RESULTS: This was an observational cohort study using the Japan Medical Data Center database, which includes claim and health examination data in Japan, between January 2005 and April 2021. In all, 133,634 gastrointestinal surgeries were included in the analysis. The primary outcome was 30-day risk of major adverse cardiovascular events (MACE). The 30-day MACE incidence rate following surgery was 3.8%. Machine learning was used to perform a binary classification task to predict MACE occurrence within 30 days after surgery. A clustering algorithm was developed based on the Shapley additive explanation values obtained from training data, and generalizability was evaluated using test data. Of the variables, age, history of ischemic heart disease or heart failure, history of stroke, diabetes, hypertension, atrial fibrillation, cases of malignancy, and pancreatic biliary surgery were identified as factors associated with MACE occurrence. CONCLUSIONS: A machine learning model built from basic clinical information, comorbidities, and surgical information demonstrated the capacity to stratify MACE risk in patients undergoing gastrointestinal surgery.

    DOI: 10.1253/circj.CJ-25-0032

    PubMed

    researchmap

  • Natural language processing of electronic medical records identifies cardioprotective agents for anthracycline induced cardiotoxicity. 国際誌

    Yoshimasa Kawazoe, Masami Tsuchiya, Kiminori Shimamoto, Tomohisa Seki, Emiko Shinohara, Shuntaro Yada, Shoko Wakamiya, Shungo Imai, Eiji Aramaki, Satoko Hori

    Scientific reports   15 ( 1 )   6678 - 6678   2025年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In this retrospective observational study, we aimed to investigate the potential of natural language processing (NLP) for drug repositioning by analyzing the preventive effects of cardioprotective drugs against anthracycline-induced cardiotoxicity (AIC) using electronic medical records. We evaluated the effects of angiotensin II receptor blockers/angiotensin-converting enzyme inhibitors (ARB/ACEIs), beta-blockers (BBs), statins, and calcium channel blockers (CCBs) on AIC using signals extracted from clinical texts via NLP. The study included 2935 patients prescribed anthracyclines at a single hospital, with concomitant prescriptions of ARB/ACEIs, BBs, statins, and CCBs. Upon propensity score matching, groups with and without these medications were compared, and expressions suggestive of cardiotoxicity, extracted via NLP, were considered as the outcome. The hazard ratios for ARB/ACEIs, BBs, statins, and CCBs were 0.58 [95% CI: 0.38-0.88], 0.71 [95% CI: 0.35-1.44], 0.60 [95% CI 0.38-0.95], and 0.63 [95% CI: 0.45-0.88], respectively. ARB/ACEIs, statins, and CCBs significantly suppressed AIC, whereas BBs did not demonstrate statistical significance, possibly due to limited statistical power. NLP-extracted signals from clinical texts reflected the known effects of these medications, demonstrating the feasibility of NLP-based drug repositioning. Further investigation is needed to determine if similar results can be replicated using electronic medical records from other institutions.

    DOI: 10.1038/s41598-025-91187-6

    PubMed

    researchmap

  • Sex Differences in Post-Noncardiac Surgery Risks Assessed Using the Revised Cardiac Risk Index - A Nationwide Retrospective Cohort Study.

    Tomohisa Seki, Yoshimasa Kawazoe, Toru Takiguchi, Yu Akagi, Hiromasa Ito, Kazumi Kubota, Kana Miyake, Masafumi Okada, Kazuhiko Ohe

    Circulation journal : official journal of the Japanese Circulation Society   2025年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The Revised Cardiac Risk Index (RCRI) has been incorporated into preoperative assessment guidelines and is used for simple preoperative screening; however, validation studies within large populations are limited. Moreover, although sex differences in perioperative risk are recognized, their effect on the performance of the RCRI remains unclear. Therefore, in this study we evaluated whether sex differences exist in the risks within the strata classified by the RCRI. METHODS AND RESULTS: The Japan Medical Data Center database based on claim and health examination data in Japan between January 2005 and April 2021 was used. A total of 161,359 noncardiac surgeries performed during hospitalization were analyzed. The main outcome was the 30-day risk of major adverse cardiovascular events. Although there was no significant sex difference among those with an RCRI ≥1, males had a significant hazard rate (1.32 [95% confidence interval, 1.03-1.68]) of postoperative events in the low-risk group with an RCRI of 0. However, this significant difference was not detected in the population excluding those who underwent breast and gynecological surgeries. CONCLUSIONS: The RCRI achieved reasonable risk stratification in validation using Japanese real-world data regardless of sex. Although further detailed analysis is necessary to determine the sex differences, the validity of using the RCRI for screening purposes is supported at this stage.

    DOI: 10.1253/circj.CJ-24-0846

    PubMed

    researchmap

  • Assessing the performance of zero-shot visual question answering in multimodal large language models for 12-lead ECG image interpretation

    Tomohisa Seki, Yoshimasa Kawazoe, Hiromasa Ito, Yu Akagi, Toru Takiguchi, Kazuhiko Ohe

    Frontiers in Cardiovascular Medicine   12   2025年2月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers Media SA  

    Large Language Models (LLM) are increasingly multimodal, and Zero-Shot Visual Question Answering (VQA) shows promise for image interpretation. If zero-shot VQA can be applied to a 12-lead electrocardiogram (ECG), a prevalent diagnostic tool in the medical field, the potential benefits to the field would be substantial. This study evaluated the diagnostic performance of zero-shot VQA with multimodal LLMs on 12-lead ECG images. The results revealed that multimodal LLM tended to make more errors in extracting and verbalizing image features than in describing preconditions and making logical inferences. Even when the answers were correct, erroneous descriptions of image features were common. These findings suggest a need for improved control over image hallucination and indicate that performance evaluation using the percentage of correct answers to multiple-choice questions may not be sufficient for performance assessment in VQA tasks.

    DOI: 10.3389/fcvm.2025.1458289

    PubMed

    researchmap

  • Iterative random forest-based identification of a novel population with high risk of complications post non-cardiac surgery. 国際誌

    Tomohisa Seki, Toru Takiguchi, Yu Akagi, Hiromasa Ito, Kazumi Kubota, Kana Miyake, Masafumi Okada, Yoshimasa Kawazoe

    Scientific reports   14 ( 1 )   26741 - 26741   2024年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Assessing the risk of postoperative cardiovascular events before performing non-cardiac surgery is clinically important. The current risk score systems for preoperative evaluation may not adequately represent a small subset of high-risk populations. Accordingly, this study aimed at applying iterative random forest to analyze combinations of factors that could potentially be clinically valuable in identifying these high-risk populations. To this end, we used the Japan Medical Data Center database, which includes claims data from Japan between January 2005 and April 2021, and employed iterative random forests to extract factor combinations that influence outcomes. The analysis demonstrated that a combination of a prior history of stroke and extremely low LDL-C levels was associated with a high non-cardiac postoperative risk. The incidence of major adverse cardiovascular events in the population characterized by the incidence of previous stroke and extremely low LDL-C levels was 15.43 events per 100 person-30 days [95% confidence interval, 6.66-30.41] in the test data. At this stage, the results only show correlation rather than causation; however, these findings may offer valuable insights for preoperative risk assessment in non-cardiac surgery.

    DOI: 10.1038/s41598-024-78482-4

    PubMed

    researchmap

  • Enhancing Antidiabetic Drug Selection Using Transformers: Machine-Learning Model Development. 国際誌

    Hisashi Kurasawa, Kayo Waki, Tomohisa Seki, Eri Nakahara, Akinori Fujino, Nagisa Shiomi, Hiroshi Nakashima, Kazuhiko Ohe

    JMIR medical informatics   13   e67748   2025年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Diabetes affects millions worldwide. Primary care physicians provide a significant portion of care, and they often struggle with selecting appropriate medications. OBJECTIVE: This study aimed to develop a model that accurately predicts what drug an endocrinologist would prescribe based on the current measurements. The goal was to create a system that would assist nonspecialists in choosing medications, thereby potentially improving diabetes treatment outcomes. Based on the performance of previous studies, we set a performance target of achieving a receiver operating characteristic area under the curve (ROC-AUC) above 0.95. METHODS: A transformer-based encoder-decoder model predicts whether 44 types of diabetes drugs will be prescribed. The model uses sequences of age, sex, history for 12 laboratory tests, and prescribed drug history as inputs. We assessed the model using the electronic health records from 7034 patients with diabetes seeing endocrinologists between 2012 and 2022 at the University of Tokyo Hospital. We assessed model performance trained on data subsets spanning different time periods (2, 5, and 10 years) using micro- and macro-averaged ROC-AUC on a hold-out test set comprising data solely from 2022. The model's performance was compared against LightGBM. RESULTS: The model trained on data from the past 5 years (2017-2021) yielded the best predictive performance, achieving a microaverage (95% CI) ROC-AUC of 0.993 (0.992-0.994) and a macroaverage (95% CI) ROC-AUC of 0.988 (0.980-0.993). The model achieved an ROC-AUC above 0.95 for 43 out of 44 drugs. These results surpassed the predefined performance target and outperformed both previous studies and the LightGBM model's microaverage ROC-AUC of 0.988 (0.985-0.990) in terms of prediction accuracy. Furthermore, training the model with short-term data from the past 5 years yielded high accuracy compared to using data from the past 10 years, suggesting that learning from more recent prescribing patterns might be advantageous. CONCLUSIONS: The proposed model demonstrates the feasibility of accurately predicting the next prescribed drugs. This model, trained from the past prescriptions of endocrinologists, has the potential to provide information that can assist nonspecialists in making diabetes-treatment decisions. Future studies will focus on incorporating important factors such as prescription contraindications and constraints to enhance safety, as well as leveraging large-scale clinical data across multiple hospitals to improve the generalizability of the model.

    DOI: 10.2196/67748

    PubMed

    researchmap

  • Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan. 国際誌

    Hiroaki Araie, Tomohisa Seki, Akira Okada, Toshimasa Yamauchi, Masaomi Nangaku, Takashi Kadowaki, Kazuhiko Ohe, Takahiro Yamauchi, Satoko Yamaguchi

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   33 ( 4 )   293 - 293   2025年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PURPOSE: While the prognosis of patients with cancer has improved, the time burden of treatment has recently been recognized as time toxicity; although, the actual clinical situation remains largely unexplored. This retrospective study aimed to elucidate the time toxicity of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with B-cell lymphoma and the factors influencing it. METHODS: We used a nationwide hospital-based database between January 2010 and November 2021 in Japan. We extracted the claims data of patients with diffuse large B-cell lymphoma and follicular lymphoma who were hospitalized and/or visited hospitals for chemotherapy. RESULTS: Among the 7760 R-CHOP administered to 2006 patients, the rate of outpatient therapy increased over time (2010-2015: 17.9%; 2016-2021: 31.8%). In 2016, the median length of hospitalization was the shortest at 13 days (IQR 8-19), which coincided with the peak use of pegylated granulocyte colony-stimulating factor (Peg-G-CSF) during hospitalization in 2015-2016, likely driven by changes in the insurance system. In multivariate analysis, the factors associated with longer hospital stays were older age and poor activities of daily living, whereas the use of Peg-G-CSF, a reduced-dose regimen, and treatment at cancer-designated hospitals were associated with shorter stays. CONCLUSION: The time toxicity of R-CHOP has improved and may be influenced by the patient's condition, adequate supportive care, changes in the insurance system, and center-specific treatment proficiency.

    DOI: 10.1007/s00520-025-09335-7

    PubMed

    researchmap

  • Predicting rapid decline in kidney function among type 2 diabetes patients: A machine learning approach

    Eri Nakahara, Kayo Waki, Hisashi Kurasawa, Imari Mimura, Tomohisa Seki, Akinori Fujino, Nagisa Shiomi, Masaomi Nangaku, Kazuhiko Ohe

    Heliyon   11 ( 1 )   2025年1月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.heliyon.2024.e40566

    Scopus

    researchmap

  • Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records. 国際誌

    Yoshimasa Kawazoe, Kiminori Shimamoto, Tomohisa Seki, Masami Tsuchiya, Emiko Shinohara, Shuntaro Yada, Shoko Wakamiya, Shungo Imai, Satoko Hori, Eiji Aramaki

    NPJ digital medicine   7 ( 1 )   315 - 315   2024年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    This study demonstrates that adverse events (AEs) extracted using natural language processing (NLP) from clinical texts reflect the known frequencies of AEs associated with anticancer drugs. Using data from 44,502 cancer patients at a single hospital, we identified cases prescribed anticancer drugs (platinum, PLT; taxane, TAX; pyrimidine, PYA) and compared them to non-treatment (NTx) group using propensity score matching. Over 365 days, AEs (peripheral neuropathy, PN; oral mucositis, OM; taste abnormality, TA; appetite loss, AL) were extracted from clinical text using an NLP tool. The hazard ratios (HRs) for the anticancer drugs were: PN, 1.15-1.95; OM, 3.11-3.85; TA, 3.48-4.71; and AL, 1.98-3.84; the HRs were significantly higher than that of the NTx group. Sensitivity analysis revealed that the HR for TA may have been underestimated; however, the remaining three types of AEs extracted from clinical text by NLP were consistently associated with the three anticancer drugs.

    DOI: 10.1038/s41746-024-01323-1

    PubMed

    researchmap

  • 大規模言語モデルに内在する医療関連エイジズムの評価手法の開発

    関 倫久, 河添 悦昌, 瀧口 徹, 赤木 雄, 伊藤 弘将, 大江 和彦

    医療情報学連合大会論文集   44回   696 - 701   2024年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医療情報学会  

    researchmap

  • A Comparative Study of Access Analysis Service Utilization on Japanese Medical Institutions' Websites with GDPR-Compliant Cases. 国際誌

    Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    Studies in health technology and informatics   316   1238 - 1242   2024年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The browsing history of a medical institution's website can potentially reveal or identify information about the health condition of the website visitor through browser cookies and fingerprints. In Japan, although the Personal Information Protection Law was revised in April 2022, the use of access analysis services to collect browsing history on medical institution websites has not been investigated. Therefore, this study investigates the actual usage of access analysis services on Japanese medical institution websites and compares it with the current situation in France, which follows the General Data Protection Regulation. The results revealed that the larger the size of the hospital, the higher the percentage of adoption of access analytics services in Japan. However, the implementation of a system for obtaining consent for the use of access analysis in Japan was found to be poor compared to that of French medical institutions. While access analysis tools are used in the websites of several medical institutions in Japan, the implementation of the process of obtaining consent to acquire browsing history is poor.

    DOI: 10.3233/SHTI240635

    PubMed

    researchmap

  • Enhancing Type 2 Diabetes Treatment Decisions With Interpretable Machine Learning Models for Predicting Hemoglobin A1c Changes: Machine Learning Model Development. 国際誌

    Hisashi Kurasawa, Kayo Waki, Tomohisa Seki, Akihiro Chiba, Akinori Fujino, Katsuyoshi Hayashi, Eri Nakahara, Tsuneyuki Haga, Takashi Noguchi, Kazuhiko Ohe

    JMIR AI   3   e56700   2024年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Type 2 diabetes (T2D) is a significant global health challenge. Physicians need to assess whether future glycemic control will be poor on the current trajectory of usual care and usual-care treatment intensifications so that they can consider taking extra treatment measures to prevent poor outcomes. Predicting poor glycemic control from trends in hemoglobin A1c (HbA1c) levels is difficult due to the influence of seasonal fluctuations and other factors. OBJECTIVE: We sought to develop a model that accurately predicts poor glycemic control among patients with T2D receiving usual care. METHODS: Our machine learning model predicts poor glycemic control (HbA1c≥8%) using the transformer architecture, incorporating an attention mechanism to process irregularly spaced HbA1c time series and quantify temporal relationships of past HbA1c levels at each time point. We assessed the model using HbA1c levels from 7787 patients with T2D seeing specialist physicians at the University of Tokyo Hospital. The training data include instances of poor glycemic control occurring during usual care with usual-care treatment intensifications. We compared prediction accuracy, assessed with the area under the receiver operating characteristic curve, the area under the precision-recall curve, and the accuracy rate, to that of LightGBM. RESULTS: The area under the receiver operating characteristic curve, the area under the precision-recall curve, and the accuracy rate (95% confidence limits) of the proposed model were 0.925 (95% CI 0.923-0.928), 0.864 (95% CI 0.852-0.875), and 0.864 (95% CI 0.86-0.869), respectively. The proposed model achieved high prediction accuracy comparable to or surpassing LightGBM's performance. The model prioritized the most recent HbA1c levels for predictions. Older HbA1c levels in patients with poor glycemic control were slightly more influential in predictions compared to patients with good glycemic control. CONCLUSIONS: The proposed model accurately predicts poor glycemic control for patients with T2D receiving usual care, including patients receiving usual-care treatment intensifications, allowing physicians to identify cases warranting extraordinary treatment intensifications. If used by a nonspecialist, the model's indication of likely future poor glycemic control may warrant a referral to a specialist. Future efforts could incorporate diverse and large-scale clinical data for improved accuracy.

    DOI: 10.2196/56700

    PubMed

    researchmap

  • Association between pupillary examinations and prognosis in patients with out-of-hospital cardiac arrest who underwent extracorporeal cardiopulmonary resuscitation: a retrospective multicentre cohort study. 国際誌

    Takuro Hamaguchi, Toru Takiguchi, Tomohisa Seki, Naoki Tominaga, Jun Nakata, Takeshi Yamamoto, Takashi Tagami, Akihiko Inoue, Toru Hifumi, Tetsuya Sakamoto, Yasuhiro Kuroda, Shoji Yokobori, The Save-J Ii Study Group

    Annals of intensive care   14 ( 1 )   35 - 35   2024年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: In some cases of patients with out-of-hospital cardiac arrest (OHCA) who underwent extracorporeal cardiopulmonary resuscitation (ECPR), negative pupillary light reflex (PLR) and mydriasis upon hospital arrival serve as common early indicator of poor prognosis. However, in certain patients with poor prognoses inferred by pupil findings upon hospital arrival, pupillary findings improve before and after the establishment of ECPR. The association between these changes in pupillary findings and prognosis remains unclear. This study aimed to clarify the association of pupillary examinations before and after the establishment of ECPR in patients with OHCA showing poor pupillary findings upon hospital arrival with their outcomes. To this end, we analysed retrospective multicentre registry data involving 36 institutions in Japan, including all adult patients with OHCA who underwent ECPR between January 2013 and December 2018. We selected patients with poor prognosis inferred by pupillary examinations, negative pupillary light reflex (PLR) and pupil mydriasis, upon hospital arrival. The primary outcome was favourable neurological outcome, defined as Cerebral Performance Category 1 or 2 at hospital discharge. Multivariable logistic regression analysis was performed to evaluate the association between favourable neurological outcome and pupillary examination after establishing ECPR. RESULTS: Out of the 2,157 patients enrolled in the SAVE-J II study, 723 were analysed. Among the patients analysed, 74 (10.2%) demonstrated favourable neurological outcome at hospital discharge. Multivariable analysis revealed that a positive PLR at ICU admission (odds ration [OR] = 11.3, 95% confidence intervals [CI] = 5.17-24.7) was significantly associated with favourable neurological outcome. However, normal pupil diameter at ICU admission (OR = 1.10, 95%CI = 0.52-2.32) was not significantly associated with favourable neurological outcome. CONCLUSION: Among the patients with OHCA who underwent ECPR and showed poor pupillary examination findings upon hospital arrival, 10.2% had favourable neurological outcome at hospital discharge. A positive PLR after the establishment of ECPR was significantly associated with favourable neurological outcome.

    DOI: 10.1186/s13613-024-01265-7

    PubMed

    researchmap

  • Factors associated with favourable neurological outcomes following cardiopulmonary resuscitation for out-of-hospital cardiac arrest: A retrospective multi-centre cohort study. 国際誌

    Naoki Tominaga, Toru Takiguchi, Tomohisa Seki, Takuro Hamaguchi, Jun Nakata, Takeshi Yamamoto, Takashi Tagami, Akihiko Inoue, Toru Hifumi, Tetsuya Sakamoto, Yasuhiro Kuroda, Shoji Yokobori

    Resuscitation plus   17   100574 - 100574   2024年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: To investigate the factors associated with favourable neurological outcomes in adult patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR) for out-of-hospital cardiac arrest (OHCA). METHODS: This retrospective observational study used secondary analysis of the SAVE-J II multicentre registry data from 36 institutions in Japan. Between 2013 and 2018, 2157 patients with OHCA who underwent ECPR were enrolled in SAVE-J II. A total of 1823 patients met the study inclusion criteria. Adult patients (aged ≥ 18 years) with OHCA, who underwent ECPR before admission to the intensive care unit, were included in our secondary analysis. The primary outcome was a favourable neurological outcome at hospital discharge, defined as a Cerebral Performance Category score of 1 or 2. We used a multivariate logistic regression model to examine the association between factors measured at the incident scene or upon hospital arrival and favourable neurological outcomes. RESULTS: Multivariable analysis revealed that shockable rhythm at the scene [odds ratio (OR); 2.11; 95% confidence interval (CI), 1.16-3.95] and upon hospital arrival (OR 2.59; 95% CI 1.60-4.30), bystander CPR (OR 1.63; 95% CI 1.03-1.88), body movement during resuscitation (OR 7.10; 95% CI 1.79-32.90), gasping (OR 4.33; 95% CI 2.57-7.28), pupillary reflex on arrival (OR 2.93; 95% CI 1.73-4.95), and male sex (OR 0.43; 95% CI 0.24-0.75) significantly correlated with neurological outcomes. CONCLUSIONS: Shockable rhythm, bystander CPR, body movement during resuscitation, gasping, pupillary reflex, and sex were associated with favourable neurological outcomes in patients with OHCA treated with ECPR.

    DOI: 10.1016/j.resplu.2024.100574

    PubMed

    researchmap

  • Graph Representation Learning-Based Fixed-Length Clinical Feature Vector Generation from Heterogeneous Medical Records. 国際誌

    Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    Studies in health technology and informatics   310   715 - 719   2024年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Transformation of patient data extracted from a database into fixed-length numerical vectors requires expertise in topical medical knowledge as well as data manipulation-thus, manual feature design is labor-intensive. In this study, we propose a machine learning-based method to for this purpose applicable to electronic medical data recorded during hospitalization, which utilizes unsupervised feature extraction based on graph embedding. Unsupervised learning is performed on a heterogeneous graph using Graph2Vec, and the inclusion of clinically useful data in the obtained embedding representation is evaluated by predicting readmission within 30 days of discharge based on it. The embedded representations are observed to improve predictive performance significantly as the information contained in the graph increases, indicating the suitability of the proposed method for feature design corresponding to clinical information.

    DOI: 10.3233/SHTI231058

    PubMed

    researchmap

  • Providing Practical Knowledge and Skills to Handle Real-World Data? Lessons Learned from Med RWD Program. 国際誌

    Kazumi Kubota, Tomohisa Seki, Kana Miyake, Masafumi Okada, Kazuyuki Nishio, Kazuhiko Ohe

    Studies in health technology and informatics   310   1540 - 1541   2024年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Both lectures and hands-on education are essential for the development of human resources that can use real-world data (RWD). The University of Tokyo has launched a new hybrid-style RWD educational program entitled "Medical Real World Data Utilization Human Resource Development Project" from FY2019 onwards. We present an overview of the overall picture of the project, including the development process of the educational program and the challenges associated with it.

    DOI: 10.3233/SHTI231283

    PubMed

    researchmap

  • Generating Counterfactual Patient Timelines from Real-World Data. 国際誌

    Yu Akagi, Tomohisa Seki, Toru Takiguchi, Hiromasa Ito, Yoshimasa Kawazoe, Kazuhiko Ohe

    AMIA ... Annual Symposium proceedings. AMIA Symposium   2024   128 - 137   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Counterfactual simulation-exploring hypothetical consequences under alternative clinical scenarios-holds promise for transformative applications such as personalized medicine and in-silico trials. However, it remains challenging due to methodological limitations. Here, we show that an autoregressive generative model, trained on real-world data from over 300,000 patients and 400 million patient timeline entries, can generate clinically plausible counterfactual trajectories. As a validation task, we applied the model to patients hospitalized with COVID-19 in 2023, modifying age, serum C-reactive protein (CRP), and serum creatinine to simulate 7-day outcomes. Increased in-hospital mortality was observed in counterfactual simulations with older age, elevated CRP, and elevated serum creatinine. Remdesivir prescriptions increased in simulations with higher CRP values and decreased in those with impaired kidney function. These counterfactual trajectories reproduced known clinical patterns. These findings suggest that autoregressive generative models trained on real-world data in a self-supervised manner can establish a foundation for counterfactual clinical simulation.

    PubMed

    researchmap

  • Immediate postnatal prediction of death or bronchopulmonary dysplasia among very preterm and very low birth weight infants based on gradient boosting decision trees algorithm: A nationwide database study in Japan. 国際誌

    Kota Yoneda, Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe, Naoto Takahashi

    PloS one   19 ( 3 )   e0300817   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: Bronchopulmonary dysplasia (BPD) poses a substantial global health burden. Individualized treatment strategies based on early prediction of the development of BPD can mitigate preterm birth complications; however, previously suggested predictive models lack early postnatal applicability. We aimed to develop predictive models for BPD and mortality based on immediate postnatal clinical data. METHODS: Clinical information on very preterm and very low birth weight infants born between 2008 and 2018 was extracted from a nationwide Japanese database. The gradient boosting decision trees (GBDT) algorithm was adopted to predict BPD and mortality, using predictors within the first 6 h postpartum. We assessed the temporal validity and evaluated model adequacy using Shapley additive explanations (SHAP) values. RESULTS: We developed three predictive models using data from 39,488, 39,096, and 40,291 infants to predict "death or BPD," "death or severe BPD," and "death before discharge," respectively. These well-calibrated models achieved areas under the receiver operating characteristic curve of 0.828 (95% CI: 0.828-0.828), 0.873 (0.873-0.873), and 0.887 (0.887-0.888), respectively, outperforming the multivariable logistic regression models. SHAP value analysis identified predictors of BPD, including gestational age, size at birth, male sex, and persistent pulmonary hypertension. In SHAP value-based case clustering, the "death or BPD" prediction model stratified infants by gestational age and persistent pulmonary hypertension, whereas the other models for "death or severe BPD" and "death before discharge" commonly formed clusters of low mortality, extreme prematurity, low Apgar scores, and persistent pulmonary hypertension of the newborn. CONCLUSIONS: GBDT models for predicting BPD and mortality, designed for use within 6 h postpartum, demonstrated superior prognostic performance. SHAP value-based clustering, a data-driven approach, formed clusters of clinical relevance. These findings suggest the efficacy of a GBDT algorithm for the early postnatal prediction of BPD.

    DOI: 10.1371/journal.pone.0300817

    PubMed

    researchmap

  • Etiology-based Prognosis of Extracorporeal Cardiopulmonary Resuscitation Recipients After Out-of-hospital Cardiac Arrest: A Retrospective Multicenter Cohort Study. 国際誌

    Toru Takiguchi, Naoki Tominaga, Takuro Hamaguchi, Tomohisa Seki, Jun Nakata, Takeshi Yamamoto, Takashi Tagami, Akihiko Inoue, Toru Hifumi, Tetsuya Sakamoto, Yasuhiro Kuroda, Shoji Yokobori

    Chest   2023年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: A better understanding of the relative contributions of various factors to patient outcomes is essential for optimal patient selection for extracorporeal cardiopulmonary resuscitation (ECPR) therapy for patients with out-of-hospital cardiac arrest (OHCA). However, evidence on the prognostic comparison based on the etiologies of cardiac arrest is limited. RESEARCH QUESTION: What is the etiology-based prognosis of patients undergoing ECPR for OHCA? STUDY DESIGN AND METHODS: This retrospective multicenter registry study involved 36 institutions in Japan and included all adult patients with OHCA who underwent ECPR between January 2013 and December 2018. The primary etiology for OHCA was determined retrospectively from all hospital-based data at each institution. We performed a multivariable logistic regression model to determine the association between etiology of cardiac arrest and two outcomes: favorable neurological outcomes and survival at hospital discharge. RESULTS: We identified 1,781 eligible patients, of whom 1,405 (78.9%) had cardiac arrest due to the cardiac causes. Multivariable logistic regression analysis for favorable neurological outcomes showed that accidental hypothermia (adjusted OR = 5.12; 95% CI = 2.98-8.80, P < 0.001) was associated with a significantly higher rate of favorable neurological outcomes than cardiac causes. Multivariable logistic regression analysis for survival showed that accidental hypothermia (adjusted OR = 5.19; 95% CI = 3.15-8.56, P < 0.001) had significantly higher rates of survival than cardiac causes. Acute aortic dissection/aneurysm (adjusted OR = 0.07, 95% CI = 0.02-0.28, P < 0.001) and primary cerebral disorders (adjusted OR = 0.12, 95% CI = 0.03-0.50, P = 0.004) had significantly lower rates of survival than cardiac causes. INTERPRETATION: In this retrospective multicenter cohort study, although most OHCA patients underwent ECPR for cardiac causes, accidental hypothermia was associated with favorable neurological outcomes and survival; in contrast, acute aortic dissection/aneurysm and primary cerebral disorders were associated with non-survival than cardiac causes.

    DOI: 10.1016/j.chest.2023.10.022

    PubMed

    researchmap

  • Sex- and Age-Based Disparities in Public Access Defibrillation, Bystander Cardiopulmonary Resuscitation, and Neurological Outcome in Cardiac Arrest. 国際誌

    Masanobu Ishii, Kenichi Tsujita, Tomohisa Seki, Masafumi Okada, Kazumi Kubota, Kenichi Matsushita, Koichi Kaikita, Naohiro Yonemoto, Yoshio Tahara, Takanori Ikeda

    JAMA network open   6 ( 7 )   e2321783   2023年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IMPORTANCE: Younger females with out-of-hospital cardiac arrest (OHCA) in public locations have less likelihood to receive public access defibrillation and bystander cardiopulmonary resuscitation (CPR). However, the association between age- and sex-based disparities and neurological outcomes remains underexamined. OBJECTIVE: To investigate the association between sex and age and the rate of receiving bystander CPR, automated external defibrillator defibrillation, and neurological outcomes in patients with OHCA. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used the All-Japan Utstein Registry, a prospective, population-based, nationwide database in Japan containing data on 1 930 273 patients with OHCA between January 1, 2005, and December 31, 2020. The cohort comprised patients with OHCA of cardiac origin that was witnessed by citizens and treated by emergency medical service personnel. The data were analyzed from September 3, 2022, to May 5, 2023. EXPOSURE: Sex and age. MAIN OUTCOMES AND MEASURES: The primary outcome was favorable neurological outcome at 30 days after an OHCA. Favorable neurological outcome was defined as a Cerebral Performance Category score of 1 (indicating good cerebral performance) or 2 (indicating moderate cerebral disability). The secondary outcomes were the rates of receiving public access defibrillation and bystander CPR. RESULTS: The 354 409 included patients who experienced bystander-witnessed OHCA of cardiac origin had a median (IQR) age of 78 (67-86) years and 136 520 were females (38.5%). The rate of receiving public access defibrillation was higher in males than females (3.2% vs 1.5%; P < .001). Stratified by age, age- and sex-based disparities in prehospital lifesaving interventions by bystanders and in neurological outcomes were observed. Although younger females had a lower rate of receiving public access defibrillation and bystander CPR than males, younger females had a higher favorable neurological outcome compared with males of the same age (odds ratio [OR], 1.19; 95% CI, 1.08-1.31). In younger females with OHCA that was witnessed by nonfamily bystanders, receiving public access defibrillation (OR, 3.51; 95% CI, 2.34-5.27) or bystander CPR (OR, 1.62; 95% CI, 1.20-2.22) was associated with a favorable neurological outcome. CONCLUSIONS AND RELEVANCE: Results of this study suggest a pattern of significant sex- and age-based differences in bystander CPR, public access defibrillation, and neurological outcomes in Japan. Improvement in neurological outcomes in patients with OHCA, especially younger females, was associated with increased use of public access defibrillation and bystander CPR.

    DOI: 10.1001/jamanetworkopen.2023.21783

    PubMed

    researchmap

  • Clinical Feature Vector Generation using Unsupervised Graph Representation Learning from Heterogeneous Medical Records. 国際誌

    Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    AMIA ... Annual Symposium proceedings. AMIA Symposium   2023   618 - 623   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The diversity of patient information recorded on electronic medical records generally, presents a challenge for converting it into fixed-length vectors that align with clinical characteristics. To address this issue, this study aimed to utilize an unsupervised graph representation learning method to transform the unstructured inpatient information from electronic medical records into a fixed-length vector. Infograph, one of the unsupervised graph representation learning algorithms was applied to the graphed inpatient information, resulting in embedded vectors of fixed length. The embedded vectors were then evaluated for whether the clinical information was preserved in it. The results indicated that the embedded representation contained information that could predict readmission within 30 days, demonstrating the feasibility of using unsupervised graph representation learning to transform patient information into fixed-length vectors that retain clinical characteristics.

    PubMed

    researchmap

  • Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning

    Jin Komuro, Yuta Tokuoka, Tomohisa Seki, Dai Kusumoto, Hisayuki Hashimoto, Toshiomi Katsuki, Takahiro Nakamura, Yohei Akiba, Thukaa Kuoka, Mai Kimura, Takahiro Yamada, Keiichi Fukuda, Akira Funahashi, Shinsuke Yuasa

    Biochemical and Biophysical Research Communications   632   181 - 188   2022年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.bbrc.2022.09.108

    researchmap

  • 機械学習を用いた糖尿病患者の腎機能のRapid Decline発現予測

    中原 英里, 田中 健太郎, 倉沢 央, 藤野 昭典, 関 倫久, 脇 嘉代, 大江 和彦

    医療情報学連合大会論文集   42回   944 - 949   2022年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医療情報学会  

    researchmap

  • 医療のリアルワールドデータを活用できる人材育成の実践と課題

    窪田 和巳, 関 倫久, 三宅 加奈, 岡田 昌史, 西尾 和幸, 大江 和彦

    医療情報学連合大会論文集   42回   965 - 968   2022年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医療情報学会  

    researchmap

  • グラフ表現学習を用いた教師なし学習による電子カルテデータ構造の自動特徴抽出手法の開発

    関 倫久, 河添 悦昌, 大江 和彦

    医療情報学連合大会論文集   42回   912 - 917   2022年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医療情報学会  

    researchmap

  • Treatment Discontinuation Prediction in Patients With Diabetes Using a Ranking Model: Machine Learning Model Development

    Hisashi Kurasawa, Kayo Waki, Akihiro Chiba, Tomohisa Seki, Katsuyoshi Hayashi, Akinori Fujino, Tsuneyuki Haga, Takashi Noguchi, Kazuhiko Ohe

    JMIR Bioinformatics and Biotechnology   3 ( 1 )   e37951 - e37951   2022年9月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:JMIR Publications Inc.  

    Background

    Treatment discontinuation (TD) is one of the major prognostic issues in diabetes care, and several models have been proposed to predict a missed appointment that may lead to TD in patients with diabetes by using binary classification models for the early detection of TD and for providing intervention support for patients. However, as binary classification models output the probability of a missed appointment occurring within a predetermined period, they are limited in their ability to estimate the magnitude of TD risk in patients with inconsistent intervals between appointments, making it difficult to prioritize patients for whom intervention support should be provided.

    Objective

    This study aimed to develop a machine-learned prediction model that can output a TD risk score defined by the length of time until TD and prioritize patients for intervention according to their TD risk.

    Methods

    This model included patients with diagnostic codes indicative of diabetes at the University of Tokyo Hospital between September 3, 2012, and May 17, 2014. The model was internally validated with patients from the same hospital from May 18, 2014, to January 29, 2016. The data used in this study included 7551 patients who visited the hospital after January 1, 2004, and had diagnostic codes indicative of diabetes. In particular, data that were recorded in the electronic medical records between September 3, 2012, and January 29, 2016, were used. The main outcome was the TD of a patient, which was defined as missing a scheduled clinical appointment and having no hospital visits within 3 times the average number of days between the visits of the patient and within 60 days. The TD risk score was calculated by using the parameters derived from the machine-learned ranking model. The prediction capacity was evaluated by using test data with the C-index for the performance of ranking patients, area under the receiver operating characteristic curve, and area under the precision-recall curve for discrimination, in addition to a calibration plot.

    Results

    The means (95% confidence limits) of the C-index, area under the receiver operating characteristic curve, and area under the precision-recall curve for the TD risk score were 0.749 (0.655, 0.823), 0.758 (0.649, 0.857), and 0.713 (0.554, 0.841), respectively. The observed and predicted probabilities were correlated with the calibration plots.

    Conclusions

    A TD risk score was developed for patients with diabetes by combining a machine-learned method with electronic medical records. The score calculation can be integrated into medical records to identify patients at high risk of TD, which would be useful in supporting diabetes care and preventing TD.

    DOI: 10.2196/37951

    researchmap

  • The complement C3-complement factor D-C3a receptor signalling axis regulates cardiac remodelling in right ventricular failure. 国際誌

    Shogo Ito, Hisayuki Hashimoto, Hiroyuki Yamakawa, Dai Kusumoto, Yohei Akiba, Takahiro Nakamura, Mizuki Momoi, Jin Komuro, Toshiomi Katsuki, Mai Kimura, Yoshikazu Kishino, Shin Kashimura, Akira Kunitomi, Mark Lachmann, Masaya Shimojima, Gakuto Yozu, Chikaaki Motoda, Tomohisa Seki, Tsunehisa Yamamoto, Yoshiki Shinya, Takahiro Hiraide, Masaharu Kataoka, Takashi Kawakami, Kunimichi Suzuki, Kei Ito, Hirotaka Yada, Manabu Abe, Mizuko Osaka, Hiromi Tsuru, Masayuki Yoshida, Kenji Sakimura, Yoshihiro Fukumoto, Michisuke Yuzaki, Keiichi Fukuda, Shinsuke Yuasa

    Nature communications   13 ( 1 )   5409 - 5409   2022年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Failure of the right ventricle plays a critical role in any type of heart failure. However, the mechanism remains unclear, and there is no specific therapy. Here, we show that the right ventricle predominantly expresses alternative complement pathway-related genes, including Cfd and C3aR1. Complement 3 (C3)-knockout attenuates right ventricular dysfunction and fibrosis in a mouse model of right ventricular failure. C3a is produced from C3 by the C3 convertase complex, which includes the essential component complement factor D (Cfd). Cfd-knockout mice also show attenuation of right ventricular failure. Moreover, the plasma concentration of CFD correlates with the severity of right ventricular failure in patients with chronic right ventricular failure. A C3a receptor (C3aR) antagonist dramatically improves right ventricular dysfunction in mice. In summary, we demonstrate the crucial role of the C3-Cfd-C3aR axis in right ventricular failure and highlight potential therapeutic targets for right ventricular failure.

    DOI: 10.1038/s41467-022-33152-9

    PubMed

    researchmap

  • Pathway importance by graph convolutional network and Shapley additive explanations in gene expression phenotype of diffuse large B-cell lymphoma. 国際誌

    Jin Hayakawa, Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    PloS one   17 ( 6 )   e0269570   2022年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Deep learning techniques have recently been applied to analyze associations between gene expression data and disease phenotypes. However, there are concerns regarding the black box problem: it is difficult to interpret why the prediction results are obtained using deep learning models from model parameters. New methods have been proposed for interpreting deep learning model predictions but have not been applied to genetics. In this study, we demonstrated that applying SHapley Additive exPlanations (SHAP) to a deep learning model using graph convolutions of genetic pathways can provide pathway-level feature importance for classification prediction of diffuse large B-cell lymphoma (DLBCL) gene expression subtypes. Using Kyoto Encyclopedia of Genes and Genomes pathways, a graph convolutional network (GCN) model was implemented to construct graphs with nodes and edges. DLBCL datasets, including microarray gene expression data and clinical information on subtypes (germinal center B-cell-like type and activated B-cell-like type), were retrieved from the Gene Expression Omnibus to evaluate the model. The GCN model showed an accuracy of 0.914, precision of 0.948, recall of 0.868, and F1 score of 0.906 in analysis of the classification performance for the test datasets. The pathways with high feature importance by SHAP included highly enriched pathways in the gene set enrichment analysis. Moreover, a logistic regression model with explanatory variables of genes in pathways with high feature importance showed good performance in predicting DLBCL subtypes. In conclusion, our GCN model for classifying DLBCL subtypes is useful for interpreting important regulatory pathways that contribute to the prediction.

    DOI: 10.1371/journal.pone.0269570

    PubMed

    researchmap

  • The Effectiveness of a Deep Learning Model to Detect Left Ventricular Systolic Dysfunction from Electrocardiograms

    Susumu Katsushika, Satoshi Kodera, Mitsuhiko Nakamoto, Kota Ninomiya, Shunsuke Inoue, Shinnosuke Sawano, Nobutaka Kakuda, Hiroshi Takiguchi, Hiroki Shinohara, Ryo Matsuoka, Hirotaka Ieki, Yasutomi Higashikuni, Koki Nakanishi, Tomoko Nakao, Tomohisa Seki, Norifumi Takeda, Katsuhito Fujiu, Masao Daimon, Hiroshi Akazawa, Hiroyuki Morita, Issei Komuro

    International Heart Journal   62 ( 6 )   1332 - 1341   2021年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:International Heart Journal (Japanese Heart Journal)  

    DOI: 10.1536/ihj.21-407

    PubMed

    researchmap

  • Deep learning model to detect significant aortic regurgitation using electrocardiography 国際誌

    Shinnosuke Sawano, Satoshi Kodera, Susumu Katsushika, Mitsuhiko Nakamoto, Kota Ninomiya, Hiroki Shinohara, Yasutomi Higashikuni, Koki Nakanishi, Tomoko Nakao, Tomohisa Seki, Norifumi Takeda, Katsuhito Fujiu, Masao Daimon, Hiroshi Akazawa, Hiroyuki Morita, Issei Komuro

    Journal of Cardiology   79 ( 3 )   334 - 341   2021年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    BACKGROUND: Aortic regurgitation (AR) is a common heart disease, with a relatively high prevalence of 4.9% in the Framingham Heart Study. Because the prevalence increases with advancing age, an upward shift in the age distribution may increase the burden of AR. To provide an effective screening method for AR, we developed a deep learning-based artificial intelligence algorithm for the diagnosis of significant AR using electrocardiography (ECG). METHODS: Our dataset comprised 29,859 paired data of ECG and echocardiography, including 412 AR cases, from January 2015 to December 2019. This dataset was divided into training, validation, and test datasets. We developed a multi-input neural network model, which comprised a two-dimensional convolutional neural network (2D-CNN) using raw ECG data and a fully connected deep neural network (FC-DNN) using ECG features, and compared its performance with the performances of a 2D-CNN model and other machine learning models. In addition, we used gradient-weighted class activation mapping (Grad-CAM) to identify which parts of ECG waveforms had the most effect on algorithm decision making. RESULTS: The area under the receiver operating characteristic curve of the multi-input model (0.802; 95% CI, 0.762-0.837) was significantly greater than that of the 2D-CNN model alone (0.734; 95% CI, 0.679-0.783; p<0.001) and those of other machine learning models. Grad-CAM demonstrated that the multi-input model tended to focus on the QRS complex in leads I and aVL when detecting AR. CONCLUSIONS: The multi-input deep learning model using 12-lead ECG data could detect significant AR with modest predictive value.

    DOI: 10.1016/j.jjcc.2021.08.029

    PubMed

    researchmap

  • Machine learning-based prediction of in-hospital mortality using admission laboratory data: A retrospective, single-site study using electronic health record data. 査読 国際誌

    Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    PloS one   16 ( 2 )   e0246640   2021年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Risk assessment of in-hospital mortality of patients at the time of hospitalization is necessary for determining the scale of required medical resources for the patient depending on the patient's severity. Because recent machine learning application in the clinical area has been shown to enhance prediction ability, applying this technique to this issue can lead to an accurate prediction model for in-hospital mortality prediction. In this study, we aimed to generate an accurate prediction model of in-hospital mortality using machine learning techniques. Patients 18 years of age or older admitted to the University of Tokyo Hospital between January 1, 2009 and December 26, 2017 were used in this study. The data were divided into a training/validation data set (n = 119,160) and a test data set (n = 33,970) according to the time of admission. The prediction target of the model was the in-hospital mortality within 14 days. To generate the prediction model, 25 variables (age, sex, 21 laboratory test items, length of stay, and mortality) were used to predict in-hospital mortality. Logistic regression, random forests, multilayer perceptron, and gradient boost decision trees were performed to generate the prediction models. To evaluate the prediction capability of the model, the model was tested using a test data set. Mean probabilities obtained from trained models with five-fold cross-validation were used to calculate the area under the receiver operating characteristic (AUROC) curve. In a test stage using the test data set, prediction models of in-hospital mortality within 14 days showed AUROC values of 0.936, 0.942, 0.942, and 0.938 for logistic regression, random forests, multilayer perceptron, and gradient boosting decision trees, respectively. Machine learning-based prediction of short-term in-hospital mortality using admission laboratory data showed outstanding prediction capability and, therefore, has the potential to be useful for the risk assessment of patients at the time of hospitalization.

    DOI: 10.1371/journal.pone.0246640

    PubMed

    researchmap

  • Anti-senescent drug screening by deep learning-based morphology senescence scoring. 査読 国際誌

    Dai Kusumoto, Tomohisa Seki, Hiromune Sawada, Akira Kunitomi, Toshiomi Katsuki, Mai Kimura, Shogo Ito, Jin Komuro, Hisayuki Hashimoto, Keiichi Fukuda, Shinsuke Yuasa

    Nature communications   12 ( 1 )   257 - 257   2021年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Advances in deep learning technology have enabled complex task solutions. The accuracy of image classification tasks has improved owing to the establishment of convolutional neural networks (CNN). Cellular senescence is a hallmark of ageing and is important for the pathogenesis of ageing-related diseases. Furthermore, it is a potential therapeutic target. Specific molecular markers are used to identify senescent cells. Moreover senescent cells show unique morphology, which can be identified. We develop a successful morphology-based CNN system to identify senescent cells and a quantitative scoring system to evaluate the state of endothelial cells by senescence probability output from pre-trained CNN optimised for the classification of cellular senescence, Deep Learning-Based Senescence Scoring System by Morphology (Deep-SeSMo). Deep-SeSMo correctly evaluates the effects of well-known anti-senescent reagents. We screen for drugs that control cellular senescence using a kinase inhibitor library by Deep-SeSMo-based drug screening and identify four anti-senescent drugs. RNA sequence analysis reveals that these compounds commonly suppress senescent phenotypes through inhibition of the inflammatory response pathway. Thus, morphology-based CNN system can be a powerful tool for anti-senescent drug screening.

    DOI: 10.1038/s41467-020-20213-0

    PubMed

    researchmap

  • リアルワールドエビデンスを創出するための臨床中核指定病院ネットワークの取り組み 臨床研究用データリソースの品質管理

    関 倫久, 永島 里美, 大江 和彦

    医療情報学連合大会論文集   40回   351 - 353   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医療情報学会  

    researchmap

  • Outcome prediction of out-of-hospital cardiac arrest with presumed cardiac aetiology using an advanced machine learning technique. 査読 国際誌

    Tomohisa Seki, Tomoyoshi Tamura, Masaru Suzuki

    Resuscitation   141   128 - 135   2019年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Outcome prediction for patients with out-of-hospital cardiac arrest (OHCA) has the possibility to detect patients who could have been potentially saved. Advanced machine learning techniques have recently been developed and employed for clinical studies. In this study, we aimed to establish a prognostication model for OHCA with presumed cardiac aetiology using an advanced machine learning technique. METHODS AND RESULTS: Cohort data from a prospective multi-centre cohort study for OHCA patients transported by an ambulance in the Kanto area of Japan between January 2012 and March 2013 (SOS-KANTO 2012 study) were analysed in this study. Of 16,452 patients, data for OHCA patients aged ≥18 years with presumed cardiac aetiology were retrieved, and were divided into two groups (training set: n = 5718, between January 1, 2012 and December 12, 2012; test set: n = 1608, between January 1, 2013 and March 31, 2013). Of 421 variables observed during prehospital and emergency department settings, 35 prehospital variables, or 35 prehospital and 18 in-hospital variables, were used for outcome prediction of 1-year survival using a random forest method. In validation using the test set, prognostication models trained with 35 variables, or 53 variables for 1-year survival showed area under the receiver operating characteristics curve (AUC) values of 0.943 (95% CI [0.930, 0.955]) and 0.958 (95% CI [0.948, 0.969]), respectively. CONCLUSIONS: The advanced machine learning technique showed favourable prediction capability for 1-year survival of OHCA with presumed cardiac aetiology. These models can be useful for detecting patients who could have been potentially saved.

    DOI: 10.1016/j.resuscitation.2019.06.006

    PubMed

    researchmap

  • Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3. 査読 国際誌

    Marina Okada, Yoshitaka Tada, Tomohisa Seki, Shugo Tohyama, Jun Fujita, Toshihiro Suzuki, Manami Shimomura, Kazuya Ofuji, Yoshikazu Kishino, Kazuaki Nakajima, Sho Tanosaki, Shota Someya, Hideaki Kanazawa, Satoru Senju, Tetsuya Nakatsura, Keiichi Fukuda

    Biochemical and biophysical research communications   511 ( 3 )   711 - 717   2019年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Immunogenicity of immature pluripotent stem cells is a topic of intense debate. Immunogenic antigens, which are specific in pluripotent states, have not been described previously. In this study, we identified glypican-3 (GPC3), a known carcinoembryonic antigen, as a pluripotent state-specific immunogenic antigen. Additionally, we validated the applicability of human leukocyte antigen (HLA)-class I-restricted GPC3-reactive cytotoxic T lymphocytes (CTLs) in the removal of undifferentiated pluripotent stem cells (PSCs) from human induced pluripotent stem cell (hiPSC)-derivatives. HiPSCs uniquely express GPC3 in pluripotent states and were rejected by GPC3-reactive CTLs, which were sensitized with HLA-class I-restricted GPC3 peptides. Furthermore, GPC3-reactive CTLs selectively removed undifferentiated PSCs from hiPSC-derivatives in vitro and inhibited tumor formation in vivo. Our results demonstrate that GPC3 works as a pluripotent state-specific immunogenic antigen in hiPSCs and is applicable to regenerative medicine as a method of removing undifferentiated PSCs, which are the main cause of tumor formation.

    DOI: 10.1016/j.bbrc.2019.02.094

    PubMed

    researchmap

  • Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes. 査読 国際誌

    Tabei R, Kawaguchi S, Kanazawa H, Tohyama S, Hirano A, Handa N, Hishikawa S, Teratani T, Kunita S, Fukuda J, Mugishima Y, Suzuki T, Nakajima K, Seki T, Kishino Y, Okada M, Yamazaki M, Okamoto K, Shimizu H, Kobayashi E, Tabata Y, Fujita J, Fukuda K

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation   38 ( 2 )   203 - 214   2019年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.healun.2018.11.002

    PubMed

    researchmap

  • Automated Deep Learning-Based System to Identify Endothelial Cells Derived from Induced Pluripotent Stem Cells. 査読 国際誌

    Dai Kusumoto, Mark Lachmann, Takeshi Kunihiro, Shinsuke Yuasa, Yoshikazu Kishino, Mai Kimura, Toshiomi Katsuki, Shogo Itoh, Tomohisa Seki, Keiichi Fukuda

    Stem cell reports   10 ( 6 )   1687 - 1695   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stemcr.2018.04.007

    Web of Science

    PubMed

    researchmap

  • Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial Infarction. 査読 国際誌

    Miyamoto K, Akiyama M, Tamura F, Isomi M, Yamakawa H, Sadahiro T, Muraoka N, Kojima H, Haginiwa S, Kurotsu S, Tani H, Wang L, Qian L, Inoue M, Ide Y, Kurokawa J, Yamamoto T, Seki T, Aeba R, Yamagishi H, Fukuda K, Ieda M

    Cell stem cell   22 ( 1 )   91 - 103   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stem.2017.11.010

    Web of Science

    PubMed

    researchmap

  • Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes 査読

    Shugo Tohyama, Jun Fujita, Chihana Fujita, Miho Yamaguchi, Sayaka Kanaami, Rei Ohno, Kazuho Sakamoto, Masami Kodama, Junko Kurokawa, Hideaki Kanazawa, Tomohisa Seki, Yoshikazu Kishino, Marina Okada, Kazuaki Nakajima, Sho Tanosaki, Shota Someya, Akinori Hirano, Shinji Kawaguchi, Eiji Kobayashi, Keiichi Fukuda

    STEM CELL REPORTS   9 ( 5 )   1406 - 1414   2017年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stemcr.2017.08.025

    Web of Science

    PubMed

    researchmap

  • Epigenetic barrier against the propagation of fluctuating gene expression in embryonic stem cells 査読

    Yuki Saito, Akira Kunitomi, Tomohisa Seki, Shugo Tohyama, Dai Kusumoto, Makoto Takei, Shin Kashimura, Hisayuki Hashimoto, Gakuto Yozu, Chikaaki Motoda, Masaya Shimojima, Toru Egashira, Mayumi Oda, Keiichi Fukuda, Shinsuke Yuasa

    FEBS LETTERS   591 ( 18 )   2879 - 2889   2017年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1002/1873-3468.12791

    Web of Science

    researchmap

  • Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient 査読

    Masaya Shimojima, Shinsuke Yuasa, Chikaaki Motoda, Gakuto Yozu, Toshihiro Nagai, Shogo Ito, Mark Lachmann, Shin Kashimura, Makoto Takei, Dai Kusumoto, Akira Kunitomi, Nozomi Hayashiji, Tomohisa Seki, Shugo Tohyama, Hisayuki Hashimoto, Masaki Kodaira, Toru Egashira, Kenshi Hayashi, Chiaki Nakanishi, Kenji Sakata, Masakazu Yamagishi, Keiichi Fukuda

    SCIENTIFIC REPORTS   7   44312   2017年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/srep44312

    Web of Science

    PubMed

    researchmap

  • Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes. 査読 国際誌

    Yusuke Kuroda, Shinsuke Yuasa, Yasuhide Watanabe, Shogo Ito, Toru Egashira, Tomohisa Seki, Tetsuhisa Hattori, Seiko Ohno, Masaki Kodaira, Tomoyuki Suzuki, Hisayuki Hashimoto, Shinichiro Okata, Atsushi Tanaka, Yoshiyasu Aizawa, Mitsushige Murata, Takeshi Aiba, Naomasa Makita, Tetsushi Furukawa, Wataru Shimizu, Itsuo Kodama, Satoshi Ogawa, Norito Kokubun, Hitoshi Horigome, Minoru Horie, Kaichiro Kamiya, Keiichi Fukuda

    Biochemistry and biophysics reports   9   245 - 256   2017年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Andersen-Tawil syndrome (ATS) is a rare inherited channelopathy. The cardiac phenotype in ATS is typified by a prominent U wave and ventricular arrhythmia. An effective treatment for this disease remains to be established. We reprogrammed somatic cells from three ATS patients to generate induced pluripotent stem cells (iPSCs). Multi-electrode arrays (MEAs) were used to record extracellular electrograms of iPSC-derived cardiomyocytes, revealing strong arrhythmic events in the ATS-iPSC-derived cardiomyocytes. Ca2+ imaging of cells loaded with the Ca2+ indicator Fluo-4 enabled us to examine intracellular Ca2+ handling properties, and we found a significantly higher incidence of irregular Ca2+ release in the ATS-iPSC-derived cardiomyocytes than in control-iPSC-derived cardiomyocytes. Drug testing using ATS-iPSC-derived cardiomyocytes further revealed that antiarrhythmic agent, flecainide, but not the sodium channel blocker, pilsicainide, significantly suppressed these irregular Ca2+ release and arrhythmic events, suggesting that flecainide's effect in these cardiac cells was not via sodium channels blocking. A reverse-mode Na+/Ca2+exchanger (NCX) inhibitor, KB-R7943, was also found to suppress the irregular Ca2+ release, and whole-cell voltage clamping of isolated guinea-pig cardiac ventricular myocytes confirmed that flecainide could directly affect the NCX current (INCX). ATS-iPSC-derived cardiomyocytes recapitulate abnormal electrophysiological phenotypes and flecainide suppresses the arrhythmic events through the modulation of INCX.

    DOI: 10.1016/j.bbrep.2017.01.002

    PubMed

    researchmap

  • Cryoinjury-induced acute myocardial infarction model and ameroid constrictor-induced ischemic heart disease model in adult micro-mini pigs for preclinical studies. 査読

    Hirano A, Fujita J, Kanazawa H, Kawaguchi S, Handa N, Yamada Y, Okuda S, Hishikawa S, Teratani T, Kunita S, Tohyama S, Seki T, Tabei R, Nakajima K, Kishino Y, Okada M, Okamoto K, Shimizu H, Kobayashi E, Fukuda K

    Translational Medicine Communications   2 ( 1 )   2017年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    researchmap

  • Embryonic type Na+ channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome. 査読

    Okata S, Yuasa S, Suzuki T, Ito S, Makita N, Yoshida T, Li M, Kurokawa J, Seki T, Egashira T, Aizawa Y, Kodaira M, Motoda C, Yozu G, Shimojima M, Hayashiji N, Hashimoto H, Kuroda Y, Tanaka A, Murata M, Aiba T, Shimizu W, Horie M, Kamiya K, Furukawa T, Fukuda K

    Scientific reports   6   34198   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/srep34198

    Web of Science

    PubMed

    researchmap

  • [Regenerative Therapy of the Cardiovascular Area Using iPS Cells]. 査読

    Fukuda K, Tohyama S, Seki T, Yuasa S, Shimoji K, Fujita J

    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine   105 ( 7 )   1287 - 1295   2016年7月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    PubMed

    researchmap

  • H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells 査読

    Akira Kunitomi, Shinsuke Yuasa, Fumihiro Sugiyama, Yuki Saito, Tomohisa Seki, Dai Kusumoto, Shin Kashimura, Makoto Takei, Shugo Tohyama, Hisayuki Hashimoto, Toru Egashira, Yoko Tanimoto, Saori Mizuno, Shoma Tanaka, Hironobu Okuno, Kazuki Yamazawa, Hideo Watanabe, Mayumi Oda, Ruri Kaneda, Yumi Matsuzaki, Toshihiro Nagai, Hideyuki Okano, Ken-ichi Yagami, Mamoru Tanaka, Keiichi Fukuda

    STEM CELL REPORTS   6 ( 6 )   825 - 833   2016年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stemcr.2016.04.015

    Web of Science

    PubMed

    researchmap

  • Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells 査読

    Shugo Tohyama, Jun Fujita, Takako Hishiki, Tomomi Matsuura, Fumiyuki Hattori, Rei Ohno, Hideaki Kanazawa, Tomohisa Seki, Kazuaki Nakajima, Yoshikazu Kishino, Marina Okada, Akinori Hirano, Takuya Kuroda, Satoshi Yasuda, Yoji Sato, Shinsuke Yuasa, Motoaki Sano, Makoto Suematsu, Keiichi Fukuda

    CELL METABOLISM   23 ( 4 )   663 - 674   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.cmet.2016.03.001

    Web of Science

    PubMed

    researchmap

  • Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes. 査読 国際誌

    Toru Egashira, Shinsuke Yuasa, Shugo Tohyama, Yusuke Kuroda, Tomoyuki Suzuki, Tomohisa Seki, Keiichi Fukuda

    Methods in molecular biology (Clifton, N.J.)   1353   343 - 53   2016年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Despite significant advances in medical treatment, cardiovascular disease is still a major cause of morbidity and mortality in advanced countries. To improve the outcome, the further promotion of basic cardiovascular science has a pivotal role for the developing novel therapeutic approach. However, due to the inaccessibility of human heart tissue, we couldn't obtain the sufficient amount of patient's heart tissues. The discovery of human-induced pluripotent stem cells (iPSCs) is highly expected to provide the breakthrough to this obstruction. Through the patient-specific iPSCs-derived cardiomyocytes, we could analyze the patient-specific heart diseases directly and repetitively. Herein we introduce the outline of creation for cardiac disease modeling using patient-specific iPSCs. Within several topics, we present the actual representative methodologies throughout the process from the derivation of cardiomyocytes to those of functional analysis.

    DOI: 10.1007/7651_2014_165

    PubMed

    researchmap

  • Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions 査読

    Yoshikazu Kishino, Tomohisa Seki, Shinsuke Yuasa, Jun Fujita, Keiichi Fukuda

    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS   ( 105 )   2015年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3791/53225

    Web of Science

    PubMed

    researchmap

  • Analysis of cardiomyocyte movement in the developing murine heart 査読

    Hisayuki Hashimoto, Shinsuke Yuasa, Hidenori Tabata, Shugo Tohyama, Tomohisa Seki, Toru Egashira, Nozomi Hayashiji, Fumiyuki Hattori, Dai Kusumoto, Akira Kunitomi, Makoto Takei, Shin Kashimura, Gakuto Yozu, Masaya Shimojima, Chikaaki Motoda, Naoto Muraoka, Kazunori Nakajima, Asako Sakaue-Sawano, Atsushi Miyawaki, Keiichi Fukuda

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   464 ( 4 )   1000 - 1007   2015年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.bbrc.2015.07.036

    Web of Science

    PubMed

    researchmap

  • Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction 査読

    Kazuaki Nakajima, Jun Fujita, Makoto Matsui, Shugo Tohyama, Noriko Tamura, Hideaki Kanazawa, Tomohisa Seki, Yoshikazu Kishino, Akinori Hirano, Marina Okada, Ryota Tabei, Motoaki Sano, Shinya Goto, Yasuhiko Tabata, Keiichi Fukuda

    PLOS ONE   10 ( 7 )   e0133308   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1371/journal.pone.0133308

    Web of Science

    PubMed

    researchmap

  • The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter Registry 査読

    Jun Fujita, Shun Kohsaka, Ikuko Ueda, Taku Inohara, Yuichiro Maekawa, Akio Kawamura, Hideaki Kanazawa, Kentaro Hayashida, Ryota Tabei, Shugo Tohyama, Tomohisa Seki, Masahiro Suzuki, Motoaki Sano, Keiichi Fukuda

    PLOS ONE   10 ( 7 )   e0133568   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1371/journal.pone.0133568

    Web of Science

    PubMed

    researchmap

  • G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy 査読

    Nozomi Hayashiji, Shinsuke Yuasa, Yuko Miyagoe-Suzuki, Mie Hara, Naoki Ito, Hisayuki Hashimoto, Dai Kusumoto, Tomohisa Seki, Shugo Tohyama, Masaki Kodaira, Akira Kunitomi, Shin Kashimura, Makoto Takei, Yuki Saito, Shinichiro Okata, Toru Egashira, Jin Endo, Toshikuni Sasaoka, Shin’ichi Takeda, Keiichi Fukuda

    Nature Communications   6   6745   2015年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/ncomms7745

    PubMed

    researchmap

  • Methods of induced pluripotent stem cells for clinical application 査読

    Tomohisa Seki, Keiichi Fukuda

    WORLD JOURNAL OF STEM CELLS   7 ( 1 )   116 - 125   2015年1月

     詳細を見る

  • Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels 査読

    Masaki Kodaira, Hideyuki Hatakeyama, Shinsuke Yuasa, Tomohisa Seki, Toru Egashira, Shugo Tohyama, Yusuke Kuroda, Atsushi Tanaka, Shinichiro Okata, Hisayuki Hashimoto, Dai Kusumoto, Akira Kunitomi, Makoto Takei, Shin Kashimura, Tomoyuki Suzuki, Gakuto Yozu, Masaya Shimojima, Chikaaki Motoda, Nozomi Hayashiji, Yuki Saito, Yu-ichi Goto, Keiichi Fukuda

    FEBS OPEN BIO   5   219 - 225   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.fob.2015.03.008

    Web of Science

    PubMed

    researchmap

  • A Massive Suspension Culture System With Metabolic Purification for Human Pluripotent Stem Cell-Derived Cardiomyocytes 査読

    Natsuko Hemmi, Shugo Tohyama, Kazuaki Nakajima, Hideaki Kanazawa, Tomoyuki Suzuki, Fumiyuki Hattori, Tomohisa Seki, Yoshikazu Kishino, Akinori Hirano, Marina Okada, Ryota Tabei, Rei Ohno, Chihana Fujita, Tomoko Haruna, Shinsuke Yuasa, Motoaki Sano, Jun Fujita, Keiichi Fukudaa

    STEM CELLS TRANSLATIONAL MEDICINE   3 ( 12 )   1473 - 1483   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.5966/sctm.2014-0072

    Web of Science

    PubMed

    researchmap

  • Endothelin-1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy-Induced Pluripotent Stem Cell-Derived Cardiomyocytes 査読

    Atsushi Tanaka, Shinsuke Yuasa, Giulia Mearini, Toru Egashira, Tomohisa Seki, Masaki Kodaira, Dai Kusumoto, Yusuke Kuroda, Shinichiro Okata, Tomoyuki Suzuki, Taku Inohara, Takuro Arimura, Shinji Makino, Kensuke Kimura, Akinori Kimura, Tetsushi Furukawa, Lucie Carrier, Koichi Node, Keiichi Fukuda

    JOURNAL OF THE AMERICAN HEART ASSOCIATION   3 ( 6 )   e001263   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1161/JAHA.114.001263

    Web of Science

    PubMed

    researchmap

  • Gelatin-hydrogel Blended Cardiomyocytes Ameliorate Cardiac Function Post Myocardial Infarction 査読

    Kazuaki Nakajima, Jun Fujita, Makoto Matsui, Shugo Tohyama, Yoshikazu Kishino, Marina Okada, Akinori Hirano, Tomohisa Seki, Yasuhiko Tabata, Keiichi Fukuda

    JOURNAL OF CARDIAC FAILURE   20 ( 10 )   S183 - S183   2014年10月

     詳細を見る

  • Time-lapse imaging of cell cycle dynamics during development in living cardiomyocyte 査読

    Hisayuki Hashimoto, Shinsuke Yuasa, Hidenori Tabata, Shugo Tohyama, Nozomi Hayashiji, Fumiyuki Hattori, Naoto Muraoka, Toru Egashira, Shinichiro Okata, Kojiro Yae, Tomohisa Seki, Takahiko Nishiyama, Kazunori Nakajima, Asako Sakaue-Sawano, Atsushi Miyawaki, Keiichi Fukuda

    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY   72   241 - 249   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.yjmcc.2014.03.020

    Web of Science

    PubMed

    researchmap

  • Derivation of Transgene-Free Human Induced Pluripotent Stem Cells from Human Peripheral T Cells in Defined Culture Conditions 査読

    Yoshikazu Kishino, Tomohisa Seki, Jun Fujita, Shinsuke Yuasa, Shugo Tohyama, Akira Kunitomi, Ryota Tabei, Kazuaki Nakajima, Marina Okada, Akinori Hirano, Hideaki Kanazawa, Keiichi Fukuda

    PLOS ONE   9 ( 5 )   e97397   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1371/journal.pone.0097397

    Web of Science

    PubMed

    researchmap

  • Generation and Characterization of Functional Cardiomyocytes Derived from Human T Cell-Derived Induced Pluripotent Stem Cells 査読

    Tomohisa Seki, Shinsuke Yuasa, Dai Kusumoto, Akira Kunitomi, Yuki Saito, Shugo Tohyama, Kojiro Yae, Yoshikazu Kishino, Marina Okada, Hisayuki Hashimoto, Makoto Takei, Toru Egashira, Masaki Kodaira, Yusuke Kuroda, Atsushi Tanaka, Shinichiro Okata, Tomoyuki Suzuki, Mitsushige Murata, Jun Fujita, Keiichi Fukuda

    PLOS ONE   9 ( 1 )   e85645   2014年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1371/journal.pone.0085645

    Web of Science

    PubMed

    researchmap

  • Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. 査読 国際誌

    Shugo Tohyama, Fumiyuki Hattori, Motoaki Sano, Takako Hishiki, Yoshiko Nagahata, Tomomi Matsuura, Hisayuki Hashimoto, Tomoyuki Suzuki, Hiromi Yamashita, Yusuke Satoh, Toru Egashira, Tomohisa Seki, Naoto Muraoka, Hiroyuki Yamakawa, Yasuyuki Ohgino, Tomofumi Tanaka, Masatoshi Yoichi, Shinsuke Yuasa, Mitsushige Murata, Makoto Suematsu, Keiichi Fukuda

    Cell stem cell   12 ( 1 )   127 - 37   2013年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stem.2012.09.013

    Web of Science

    PubMed

    researchmap

  • Distinct iPS cells show different cardiac differentiation efficiency 査読

    Yohei Ohno, Shinsuke Yuasa, Toru Egashira, Tomohisa Seki, Hisayuki Hashimoto, Shugo Tohyama, Yuki Saito, Akira Kunitomi, Kenichiro Shimoji, Takeshi Onizuka, Toshimi Kageyama, Kojiro Yae, Tomofumi Tanaka, Ruri Kaneda, Fumiyuki Hattori, Mitsushige Murata, Kensuke Kimura, Keiichi Fukuda

    Stem Cells International   2013   659739   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Hindawi Publishing Corporation  

    DOI: 10.1155/2013/659739

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Myocardial cell sheet therapy and cardiac function 査読

    Jun Fujita, Yuji Itabashi, Tomohisa Seki, Shugo Tohyama, Yuichi Tamura, Motoaki Sano, Keiichi Fukuda

    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY   303 ( 10 )   H1169 - H1182   2012年11月

     詳細を見る

  • Disease characterization using LQTS-specific induced pluripotent stem cells 査読

    Toru Egashira, Shinsuke Yuasa, Tomoyuki Suzuki, Yoshiyasu Aizawa, Hiroyuki Yamakawa, Tomohiro Matsuhashi, Yohei Ohno, Shugo Tohyama, Shinichiro Okata, Tomohisa Seki, Yusuke Kuroda, Kojiro Yae, Hisayuki Hashimoto, Tomofumi Tanaka, Fumiyuki Hattori, Toshiaki Sato, Shunichiro Miyoshi, Seiji Takatsuki, Mitsushige Murata, Junko Kurokawa, Tetsushi Furukawa, Naomasa Makita, Takeshi Aiba, Wataru Shimizu, Minoru Horie, Kaichiro Kamiya, Itsuo Kodama, Satoshi Ogawa, Keiichi Fukuda

    CARDIOVASCULAR RESEARCH   95 ( 4 )   419 - 429   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1093/cvr/cvs206

    Web of Science

    PubMed

    researchmap

  • Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus 査読

    Tomohisa Seki, Shinsuke Yuasa, Keiichi Fukuda

    NATURE PROTOCOLS   7 ( 4 )   718 - 728   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/nprot.2012.015

    Web of Science

    PubMed

    researchmap

  • Derivation of induced pluripotent stem cells from human peripheral circulating T cells. 査読 国際誌

    Tomohisa Seki, Shinsuke Yuasa, Keiichi Fukuda

    Current protocols in stem cell biology   Chapter 4   Unit4A.3   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    This unit describes a protocol for the generation of induced pluripotent stem (iPS) cells from human peripheral circulating T cells. Initially, human dermal fibroblasts and retroviral vectors were used to generate human iPS cells. Invasive approaches, such as skin biopsy, and genomic insertion of transgenes into the host genome are not appropriate for routine clinical application. Peripheral circulating T cells are readily available from blood samples of patients and healthy volunteers. For the efficient generation of human iPS cells, efficient introduction of the transgene into host cells is necessary. Using a combination of activated T cell culture and Sendai virus allows for the easy and efficient introduction of transgenes into activated T cells and the generation of human iPS cells without genomic integration of extrinsic genes. The T cell-derived iPS (TiPS) cells exhibit monoclonal T cell receptor (TCR) rearrangement in their genome, a hallmark of mature terminally differentiated T cells.

    DOI: 10.1002/9780470151808.sc04a03s18

    PubMed

    researchmap

  • Generation and clinical application of human T cell-derived induced pluripotent stem cells

    Seki Tomohisa, Yuasa Shinsuke, Fukuda Keiichi

    Inflammation and Regeneration   31 ( 5 )   393 - 398   2011年

     詳細を見る

    記述言語:英語   出版者・発行元:The Japanese Society of Inflammation and Regeneration  

    Pluripotent stem (iPS) cells are a very promising cell source for models of human genetic diseases and revolutionary new therapies. Successful reprogramming of human blood cells has been reported and is likely to advance the clinical application of iPS cells. In terms of a patient's own somatic cells, generating iPS cells from peripheral blood cells has advantages for clinical applications because these cells are an easily accessible cell source. Of the human peripheral blood cells, T cells can be readily cultured in vitro and proliferate rapidly. Furthermore, only a small amount of peripheral blood is needed to generate iPS cells from T cells, thus increasing the number of patients in whom the technique can be used. iPS cells that contain T-cell receptor (TCR) rearrangements in their genome also have the potential to be traceable markers when establishing novel transplantation therapies. The present review summarizes recent progress in the methods used to generate iPS cells and the future potential of human T cell-derived iPS cells.

    DOI: 10.2492/inflammregen.31.393

    CiNii Article

    researchmap

  • Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells 査読

    Tomohisa Seki, Shinsuke Yuasa, Mayumi Oda, Toru Egashira, Kojiro Yae, Dai Kusumoto, Hikari Nakata, Shugo Tohyama, Hisayuki Hashimoto, Masaki Kodaira, Yohei Okada, Hiroyuki Seimiya, Noemi Fusaki, Mamoru Hasegawa, Keiichi Fukuda

    CELL STEM CELL   7 ( 1 )   11 - 14   2010年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stem.2010.06.003

    Web of Science

    PubMed

    researchmap

  • Zac1 Is an Essential Transcription Factor for Cardiac Morphogenesis 査読

    Shinsuke Yuasa, Takeshi Onizuka, Kenichiro Shimoji, Yohei Ohno, Toshimi Kageyama, Sung Han Yoon, Toru Egashira, Tomohisa Seki, Hisayuki Hashimoto, Takahiko Nishiyama, Ruri Kaneda, Mitsushige Murata, Fumiyuki Hattori, Shinji Makino, Motoaki Sano, Satoshi Ogawa, Owen W. J. Prall, Richard P. Harvey, Keiichi Fukuda

    CIRCULATION RESEARCH   106 ( 6 )   1083 - 1091   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1161/CIRCRESAHA.109.214130

    Web of Science

    PubMed

    researchmap

  • G-CSF Promotes the Proliferation of Developing Cardiomyocytes In Vivo and in Derivation from ESCs and iPSCs 査読

    Kenichiro Shimoji, Shinsuke Yuasa, Takeshi Onizuka, Fumiyuki Hattori, Tomofumi Tanaka, Mie Hara, Yohei Ohno, Hao Chen, Toru Egasgira, Tomohisa Seki, Kojiro Yae, Uichi Koshimizu, Satoshi Ogawa, Keiichi Fukuda

    CELL STEM CELL   6 ( 3 )   227 - 237   2010年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stem.2010.01.002

    Web of Science

    PubMed

    researchmap

  • In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes 査読

    Tomofumi Tanaka, Shugo Tohyama, Mitsushige Murata, Fumimasa Nomura, Tomoyuki Kaneko, Hao Chen, Fumiyuki Hattori, Toru Egashira, Tomohisa Seki, Yohei Ohno, Uichi Koshimizu, Shinsuke Yuasa, Satoshi Ogawa, Shinya Yamanaka, Kenji Yasuda, Keiichi Fukuda

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   385 ( 4 )   497 - 502   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.bbrc.2009.05.073

    Web of Science

    PubMed

    researchmap

  • Composite metastatic carcinoma in lymph nodes of patients with concurrent medullary and papillary thyroid carcinoma: A report of two cases 査読

    Tomohisa Seki, Kaori Kameyama, Hiroshi Hayashi, Mitsuji Nagahama, Katsuhiko Masudo, Nobuhiro Fukunari, Kumi Tanaka, Kiminori Sugino, Koichi Ito, Hiroshi Takami

    Endocrine Pathology   15 ( 1 )   83 - 88   2004年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1385/EP:15:1:83

    Scopus

    PubMed

    researchmap

▼全件表示

MISC

  • 超高齢社会におけるエイジズムと医療AI

    関 倫久, 河添 悦昌

    日本糖尿病インフォマティクス学会誌   24   28 - 33   2025年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本糖尿病インフォマティクス学会  

    researchmap

  • 生活習慣病と医療ビッグデータ

    関倫久, 大江和彦

    医学のあゆみ   278 ( 5 )   2021年

     詳細を見る

  • 精密医療実現に向けた電子カルテデータの利活用 招待

    関倫久

    もっとよくわかる!循環器学と精密医療   182 - 187   2020年3月

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(商業誌、新聞、ウェブメディア)  

    researchmap

  • 人工知能のすべて 招待

    関倫久

    科学雑誌 Newton 2019年9月号 (分担監修)   2019年9月

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(商業誌、新聞、ウェブメディア)  

    researchmap

  • 院外心停止患者の転帰改善に向けて 心原性院外心停止患者の予後予測への機械学習技術の適用性の検討

    関 倫久, 多村 知剛, 鈴木 昌

    日本救急医学会雑誌   29 ( 10 )   374 - 374   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本救急医学会  

    researchmap

  • 補体副経路を標的とした右室起源致死性不整脈に対する新たな治療法の開発

    伊藤 章吾, 関 倫久, 湯浅 慎介, 小室 仁, 勝木 俊臣, 木村 舞, 岸野 喜一, 楠本 大, 鈴木 邦道, 柚崎 通介, 福田 恵一

    補体   55 ( 1 )   48 - 49   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本補体学会  

    researchmap

  • 臨床応用前夜となったiPS細胞による心筋再生医療の今後の展開

    福田恵一, 遠山周吾, 関倫久, 中嶋一晶, 湯浅慎介, 金澤英明, 藤田淳

    日本循環制御医学会総会・学術集会プログラム・抄録集   39th   2018年

     詳細を見る

  • Clinical application of human iPS cells for the treatment of patients with severe congestive heart failure

    K. Keiichi Fukuda, J. Fujita, S. Tohyama, T. Seki, S. Yuasa

    EUROPEAN JOURNAL OF HEART FAILURE   19   514 - 514   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • 臨床応用前夜となったiPS細胞による心筋再生医療の今後の展開

    福田恵一, 遠山周吾, 金澤英明, 関倫久, 中嶋一晶, 藤田淳, 湯浅慎介

    日本心臓病学会学術集会(Web)   65th   2017年

     詳細を見る

  • Disease Characterization of Long QT Syndrome Using iPS Cell-Derived Cardiomyocytes

    Keiichi Fukuda, Toru Egashira, Tomohisa Seki, Shinsuke Yuasa

    journal of arrhythmia   27 ( 4 )   246   2017年

     詳細を見る

    記述言語:英語  

    DOI: 10.4020/jhrs.27.PL

    Scopus

    researchmap

  • 20年後の再生医療を予測する 循環器領域へのiPS細胞の臨床応用の現状

    福田 恵一, 遠山 周吾, 関 倫久, 湯浅 慎介, 藤田 淳

    循環器専門医   24 ( 2 )   242 - 251   2016年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本循環器学会  

    researchmap

  • iPS細胞を用いた循環器領域の再生医療

    福田恵一, 遠山周吾, 関倫久, 湯浅慎介, 下地顕一郎, 藤田淳

    日本内科学会雑誌   105 ( 7 )   1287‐1295   2016年7月

     詳細を見る

    記述言語:日本語  

    DOI: 10.2169/naika.105.1287

    J-GLOBAL

    researchmap

  • The Modeling of Werner Syndrome by Induced Pluripotent Stem Cells

    Gakuto Yozu, Shinsuke Yuasa, Chikaaki Motoda, Dai Kusumoto, Akira Kunitomi, Shin Kashimura, Makoto Takei, Masaya Shimojima, Nozomi Hayashiji, Tomohisa Seki, Shugo Tohyama, Koutaro Yokote, Hiroyuki Daita, Keiichi Fukuda

    CIRCULATION   132   2015年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • The Clinical Characteristics of Patients With Ischemia-oriented or Coronary Computed Tomography Angiography-oriented Percutaneous Coronary Intervention, a Report From the Multicenter Registry

    Jun Fujita, Shun Kohsaka, Ikuko Ueda, Taku Inohara, Yuichiro Maekawa, Akio Kawamura, Hideaki Kanazawa, Kentaro Hayashida, Ryota Tabei, Shugo Tohyama, Tomohisa Seki, Masahiro Suzuki, Motoaki Sano, Keiichi Fukuda

    CIRCULATION   132   2015年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • 心筋再生の現状と展望 臨床応用へ向けた再生医療用iPS細胞樹立法

    関倫久, 福田恵一

    最新医学   70 ( 8 )   1595 - 1603   2015年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:最新医学社  

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • Uncontrolled Endothelial Migration In Hereditary Hemorrhagic Telangiectasia: Disease Modeling With Ips Cell

    Makoto Takei, Shinsuke Yuasa, Dai Kusumoto, Akira Kunitomi, Shin Kashiumura, Gakuto Yodu, Masaya Shimojima, Chikaaki Motoda, Atsushi Tanaka, Yusuke Kuroda, Shugo Tohyama, Tomohisa Seki, Keiichi Fukuda

    CIRCULATION RESEARCH   117   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • スピナーフラスコを用いたヒトiPS細胞における大量心筋分化誘導および純化精製法の確立

    邉見奈津子, 遠山周吾, 中嶋一晶, 金澤英明, 服部文幸, 関倫久, 岸野喜一, 平野暁教, 岡田麻里奈, 田部井亮太, 大野麗, 藤田千花, 春名友子, 藤田淳, 福田恵一

    再生医療   14   369   2015年2月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • T細胞由来iPS細胞の再生医療への応用

    関倫久, 岸野喜一, 湯浅慎介, 藤田淳, 福田恵一

    再生医療   14   140   2015年2月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • ゼラチンハイドロゲルを使用した,不全心に対する心筋細胞移植による急性期機能改善と移植効率の検討

    中嶋一晶, 藤田淳, 松井誠, 遠山周吾, 金澤英明, 関倫久, 岸野喜一, 平野暁教, 岡田麻里奈, 邉見奈津子, 田部井亮太, 大野麗, 佐野元昭, 田畑泰彦, 福田恵一

    日本心臓病学会学術集会抄録(CD-ROM)   62nd   ROMBUNNO.P-537 - 537   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本心臓病学会  

    J-GLOBAL

    researchmap

  • 分化誘導に適したiPS細胞株選抜を目的としたiPS細胞株間の遺伝子発現の差異の解析

    関倫久, 湯浅慎介, 楠本大, 國富晃, 岸野喜一, 斎藤優樹, 岡田麻里奈, 藤田淳, 福田恵一

    再生医療   13   205   2014年1月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Novel Pathological Detection System of Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using T-Cell Receptor Gene Locus for Cell Transplantation Therapy

    Yoshikazu Kishino, Tomohisa Seki, Shugo Tohyama, Shinsuke Yuasa, Jun Fujita, Motoaki Sano, Keiichi Fukuda

    CIRCULATION   128 ( 22 )   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • 循環器疾患における再生医療の展望 循環器領域での再生医療の実践にむけて

    関倫久, 福田恵一

    循環plus   14 ( 1 )   10 - 12   2013年10月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 循環器再生医療の現状と展望 iPS細胞の樹立法の現状と課題

    関倫久

    月刊循環器   3 ( 9 )   6 - 13   2013年9月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • メタボローム解析を利用したヒトiPS由来再生心筋細胞の純化精製法の開発

    福田恵一, 遠山周吾, 関倫久, 湯浅慎介, 服部文幸, 藤田淳

    再生医療   12   96   2013年2月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 再生医療の実現化に向けて iPS細胞を用いた再生心筋移植による重症心不全治療法の確立

    関倫久, 福田恵一

    炎症と免疫   21 ( 2 )   136 - 141   2013年2月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 末梢血中の終末分化したヒトT細胞からのiPS細胞樹立

    関倫久, 湯浅慎介, 福田恵一

    医学のあゆみ   239 ( 14 )   1320 - 1325   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:医歯薬出版  

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • 心不全とiPS細胞

    関倫久, 福田恵一

    Circ Up date   6 ( 4 )   416 - 421   2011年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:メディカ出版  

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • 最新基礎科学 知っておきたい 1滴の血液からiPS細胞

    関倫久, 湯浅慎介, 福田恵一

    臨床整形外科   46 ( 4 )   354 - 357   2011年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:医学書院  

    DOI: 10.11477/mf.1408101965

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • 末梢血0.1mLからのiPS細胞樹立技術

    関倫久, 湯浅慎介, 福田恵一

    メディカルバイオ   7 ( 6 )   22 - 27   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:オーム社  

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • Novel Method 'Fucci' Elucidated the Cardiomyocyte Cell Cycle Dynamics in Various Life Stages

    Hisayuki Hashimoto, Shinsuke Yuasa, Shugo Tohyama, Tomohisa Seki, Toru Egashira, Kojiro Yae, Dai Kusumoto, Masaki Kodaira, Fumiyuki Hattori, Naoto Muraoka, Hidenori Tabata, Kazunori Nakajima, Asako Sakaue-Sawano, Atsushi Miyawaki, Keiichi Fukuda

    CIRCULATION   122 ( 21 )   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • iPS細胞の心疾患病態解明への応用

    関倫久, 福田恵一

    呼吸と循環   57 ( 11 )   1155 - 1159   2009年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:医学書院  

    DOI: 10.11477/mf.1404101370

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • Functional Characterization of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes

    Shugo Tohyama, Mitsushige Murata, Fumiyuki Hattori, Tomofumi Tanaka, Hao Chen, Hiromi Yamashita, Yusuke Sato, Toru Egashira, Tomohisa Seki, Hisayuki Hashimoto, Yohei Ohno, Yuichi Tamura, Shinsuke Yuasa, Satoshi Ogawa, Keiichi Fukuda

    CIRCULATION   120 ( 18 )   S723 - S723   2009年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • Molecular Characterization of Induced Pluripotent Stem (iPS) Cell-Derived Cardiomyocytes

    Yohei Ohno, Shinsuke Yuasa, Toru Egashira, Tomohisa Seki, Hisayuki Hashimoto, Shugo Toyama, Sung Han Yoon, Takahide Arai, Chen Hao, Tomofumi Tanaka, Fumiyuki Hattori, Kojiro Yae, Mitsushige Murata, Satoshi Ogawa, Shinya Yamanaka, Keiichi Fukuda

    CIRCULATION   120 ( 18 )   S765 - S765   2009年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

  • Generation of Induced Pluripotent Stem Cells in Healthy Volunteers and Patients With Hereditary Heart Disease

    Toru Egashira, Shinsuke Yuasa, Yohei Ohno, Tomohisa Seki, Hisayuki Hashimoto, Shogo Toyama, Sung H. Yoon, Chen Hao, Tomofumi Tanaka, Fumiyuki Hattori, Kojiro Yae, Mitsushige Murata, Satoshi Ogawa, Keiichi Fukuda

    CIRCULATION   120 ( 18 )   S619 - S619   2009年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)  

    Web of Science

    researchmap

▼全件表示

講演・口頭発表等

  • Evaluation of Medical Domain-Specific Large Language Models for Clinical Decision Support using Heart Failure Guideline-based Questions

    関倫久

    第90回日本循環器学会学術集会  2026年3月20日 

     詳細を見る

    開催年月日: 2026年3月20日 - 2026年3月22日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • 大規模言語モデルの医療関連エイジズム軽減・回避のためのシステムプロンプト評価

    関倫久

    第45回医療情報学連合大会(第26回日本医療情報学会学術大会)  2025年11月14日 

     詳細を見る

    開催年月日: 2025年11月12日 - 2025年11月15日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • Assessment of Medically Relevant Ageism Inherent in Large Language Models

    Tomohisa Seki, Yoshimasa Kawazoe, Hiromasa Ito, Toru Takiguchi, Yu Akagi, Memi Ebara, Kazuhiko Ohe

    MEDINFO25  2025年8月13日 

     詳細を見る

    開催年月日: 2025年8月9日 - 2025年8月14日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • Verification of Validity and Sex Differences of the RCRI in Non-cardiac Surgery using Real-world Data in Japan

    関倫久

    第89回日本循環器学会学術集会  2025年3月29日 

     詳細を見る

    開催年月日: 2025年3月28日 - 2025年3月30日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • 大規模言語モデルに内在する医療関連エイジズム評価

    関倫久

    第44回医療情報学連合大会(第25回日本医療情報学会学術大会)  2024年11月22日 

     詳細を見る

    開催年月日: 2024年11月21日 - 2024年11月24日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • A Comparative Study of Access Analysis Service Utilization on Japanese Medical Institutions' Websites with GDPR-Compliant Cases

    Tomohisa Seki

    MIE 2024 34th Medical Informatics Europe Conference  2024年8月29日 

     詳細を見る

    開催年月日: 2024年8月25日 - 2024年8月29日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • 教育講演2 超高齢社会におけるエイジズムと医療AI 招待

    関倫久

    第24回日本糖尿病インフォマティクス学会年次学術集会  2024年8月17日 

     詳細を見る

    開催年月日: 2024年8月17日 - 2024年8月18日

    記述言語:日本語  

    researchmap

  • 教育セッションII AIハンズオン2 画像解析 招待

    関倫久

    日本循環器学会関東甲信越地方会  2023年12月16日 

     詳細を見る

    開催年月日: 2023年12月16日

    記述言語:日本語   会議種別:公開講演,セミナー,チュートリアル,講習,講義等  

    researchmap

  • Clinical Feature Vector Generation using Unsupervised Graph Representation Learning from Heterogeneous Medical Records

    Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    AMIA 2023 Nannual Symposium  2023年11月15日 

     詳細を見る

    開催年月日: 2023年11月11日 - 2023年11月15日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • Graph representation learning-based fixed-length clinical feature vector generation from heterogeneous medical records

    Tomohisa Seki, Yoshimasa Kawazoe, Kazuhiko Ohe

    MEDINFO23  2023年7月11日 

     詳細を見る

    開催年月日: 2023年7月8日 - 2023年7月12日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • グラフ表現学習を用いた教師なし学習による電子カルテデータ構造の自動特徴抽出手法の開発

    関 倫久, 河添 悦昌, 大江 和彦

    第42回医療情報学連合大会(第23回日本医療情報学会学術大会)  2022年11月19日 

     詳細を見る

    開催年月日: 2022年11月17日 - 2022年11月20日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 臨床研究用データリソースの品質管理

    関倫久, 永島里美, 大江和彦

    第40回医療情報学連合大会・第21回日本医療情報学会学術大会  2020年11月20日 

     詳細を見る

    開催年月日: 2020年11月18日 - 2020年11月23日

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(公募)  

    researchmap

  • 医療リアルワールドデータの利活用促進に向けた機械学習の応用 招待

    関倫久

    第24回日本抗加齢医学会総会  2024年6月2日 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(招待・特別)  

    researchmap

  • SS-MIX2標準化ストレージを用いた入院後の死亡退院リスク予測モデルの開発

    関倫久, 河添悦昌, 大江和彦

    第39回医療情報学連合大会・第20回日本医療情報学会学術大会  2019年11月22日 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • Machine Learning Models for Outcome Prediction of Out-Of-Hospital Cardiac Arrest of Presumed Cardiac Cause Using the All-Japan Utstein Registry

    関倫久

    Resuscitation Science Symposium 2019  2019年11月17日 

     詳細を見る

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • Prognostication for out-of-hospital cardiogenic cardiac arrest patients using advanced machine learning technique

    関倫久

    日本循環器学会総会・学術総会  2019年 

     詳細を見る

    記述言語:英語  

    researchmap

  • 機械学習による心原性成人院外心停止の長期予後予測モデルの作成

    関倫久

    日本救急医学会総会・学術集会  2018年 

     詳細を見る

  • Prognostication for Out-of-Hospital Cardiogenic Cardiac Arrest Patients Using Advanced Machine Learning Technique

    Resuscitation Science Symposium  2018年 

     詳細を見る

  • Analysis of cardiomyocytes differentiated from ips cell from patients with familial ASD/VSD patients

    関倫久

    Keystone Symposia Conference  2016年 

     詳細を見る

  • Analysis of Differences in Gene Expression Patterns of Human Induced Pluripotent Stem Cells for Selection of Cell Lines Suitable for Differentiation

    関倫久

    ISSCR 13th Annual Meeting,  2015年 

     詳細を見る

  • Analysis of cardiomyocytes differentiated from ips cell from patients with familial ASD/VSD patients.

    関倫久

    ISSCR 13th Annual Meeting  2015年 

     詳細を見る

  • T細胞由来iPS細胞の再生医療への応用

    関倫久

    日本再生医療学会総会  2015年 

     詳細を見る

  • 分化誘導に適したiPS細胞株選抜を目的としたiPS細胞株間の遺伝子発現の差異の解析.

    関倫久

    日本再生医療学会総会  2014年 

     詳細を見る

  • Derivation of Functional Cardiomyocytes Using Human Peripheral T cell Derived Induced Pluripotent Stem Cells.

    関倫久

    日本循環器学会総会・学術集会  2012年 

     詳細を見る

  • Drivation of functional cardiomyocytes from human peripheral T cell derived induced pluripotent stem cells.

    関倫久

    Internal society of stem cell reseach  2012年 

     詳細を見る

  • Human peripheral T cell derived induced pluripotent stem cells can differentiate into functional cardiomyocyte.

    関倫久

    日本循環器学会総会・学術集会  2011年 

     詳細を見る

  • Generation of Induced Pluripotent Stem (iPS) Cells from Patients with Congenital Long QT Syndrome.

    関倫久

    日本循環器学会総会・学術集会  2010年 

     詳細を見る

▼全件表示

受賞

  • 第42回医療情報学連合大会学術奨励賞 優秀口演賞

    2023年6月   医療情報学会   グラフ表現学習を用いた教師なし学習による電子カルテデータ構造の自動特徴抽出手法の開発

    関倫久

     詳細を見る

  • Paul Dudley International Scholar Award

    2019年11月   AHA Resuscitation Science Symposium  

    関倫久

     詳細を見る

  • 東京都医師会医学研究賞奨励賞

    2012年5月   東京都医師会  

    関倫久

     詳細を見る

  • 井上研究奨励賞

    2011年12月   井上科学振興財団  

    関倫久

     詳細を見る

  • 育志賞

    2011年2月   日本学術振興会  

    関倫久

     詳細を見る

共同研究・競争的資金等の研究

  • 医療における年齢差別の克服のための評価基盤構築

    研究課題/領域番号:26K13105  2026年04月 - 2029年03月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    関 倫久

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    researchmap

  • AIを用いたJ波症候群における致死性不整脈発生の概日リズム解析と時間治療への応用

    研究課題/領域番号:26K11064  2026年04月 - 2029年03月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    相澤 義泰, 関倫久

      詳細を見る

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    researchmap

  • メタボに固執した特定健診からの脱却:real world dataを用いたAIによる評価法の創出

    研究課題/領域番号:24K13502  2024年04月 - 2027年03月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    川野 貴久, 関 倫久

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    researchmap

  • 個別化医療の実現を目指したマルチモーダル汎用モデル開発

    研究課題/領域番号:23K28181  2023年04月 - 2026年03月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    小寺 聡, 関 倫久, 鈴木 雅大

      詳細を見る

    配分額:18850000円 ( 直接経費:14500000円 、 間接経費:4350000円 )

    2023年度の研究活動は、マルチモーダルAIアプローチを利用した冠動脈疾患(IHD)患者のリスク評価の有効性と、医療領域に特化した大規模言語モデル(LLM)の適応性に関する2つの研究開発を重点的に行った。研究開発1では、心電図(ECG)と胸部X線(CXR)のデータを組み合わせた深層ニューラルネットワーク(DNN)を用いて、冠動脈疾患患者を4つのリスクグループに分類した。この分類に基づく多変量Coxハザード解析を通じて、Dual-modality high-riskグループにおいて、重大な心血管イベント(MACE)の発生率が他グループに比べて有意に高いことが確認された。これにより、マルチモーダルな診断アプローチが冠動脈疾患患者のリスク評価において極めて重要であることが明らかになった。研究開発2では、医療領域へのLLMの適応が重要な課題とされている。特に、低ランク適応(LoRA)を用いた指示調整が、日本語医療問題解決タスクにおいてどのように性能向上に寄与するかを評価した。多肢選択問題を用いた実験で、LoRA調整が特定領域の知識を効果的にモデルに組み込むことができることが示された。このアプローチにより、英語中心のモデルを日本語に適応させることが可能となり、医療機関が独自にモデルを調整し、運用するための基盤が築かれた。これらの研究は、個別化医療を実現するためのAI技術の進展に大きく寄与し、具体的な臨床応用に向けた重要なステップとなっている。今後も、これらの技術をさらに発展させ、実際の医療現場での応用を目指して取り組む予定である。

    researchmap

  • グラフ表現学習を用いた教師なし学習による疾患・病態特徴の自動抽出手法の開発

    研究課題/領域番号:23K11865  2023年04月 - 2026年03月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    関 倫久

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    researchmap

  • 患者本人の主観的評価(PRO)を活用した循環器疾患レジストリデータの統合的解析

    研究課題/領域番号:23K20336  2020年04月 - 2025年03月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    香坂 俊, 隈丸 拓, 関 倫久

      詳細を見る

    配分額:16640000円 ( 直接経費:12800000円 、 間接経費:3840000円 )

    循環器疾患領域での現代の RCT はそのほとんどが全死亡、心血管死亡といった「臨床的なイベントの発生」の評価を一次エンドポイントとして実施される。こうしたイベントに関する情報は患者予後と直結しているが、慢性疾患においては患者側の視点を備えたQOLなどのエンドポイントを重要視しなくてはならない。本研究では、既存の多施設共同疾患登録レジストリのプラットフォームを用いて循環器腫瘍疾患に特異的な Patient-Reported Outcome (PRO)ドメインの情報収集を行うこととしている。
    <BR>
    本年度は心不全、心房細動領域から多くの成果が得られた。心不全に関してはスタンフォード大学との共同研究により、重要な医療の質の指標である GDMT(診療ガイドラインで推奨されている薬剤)の処方状況の把握を行っている(JAMA Cardiology 2021 等)。今後日米の両施設で PRO の取得を同患者に対して行い、GDMT処方率への関与推計していく。心房細動は全例から PRO を取得しているレジストリより各種の治療介入(アブレーションや薬剤治療)による効果に関して検討を行っている(Europace 2022, Am Heart J 2022 等)。
    <BR>
    この他冠動脈疾患領域においても医療の質向上全般に向けて総説や大規模データ解析などを実施し、成果をあげ、学会などのシンポジウムでも発表させていただいている。

    researchmap

  • 蘇生救急領域における診療支援を目的とした機械学習モデルの開発

    研究課題/領域番号:20K09302  2020年04月 - 2023年03月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    関 倫久

      詳細を見る

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    総務省消防庁の救急蘇生統計(ウツタインデータ)を利用した心原性心肺停止の予後予測モデルの開発に取り組み、後方視的に救命可能性が高いにもかかわらず救命できなかった心肺停止例の検出モデルの作成を試みた。58万件の心原性心肺停止例を学習データとし、22万件をテストデータとしてロジスティック回帰、多層パーセプトロン、ランダムフォレストを用いて神経学的予後を予測する機械学習モデルを作成し、AUROCで0.94を超える予測性能を達成するモデルは作成可能であったが、不均衡データであることからさらなる評価が必要であるとともに、実用・実装に向け入力時の欠損値への対応とそれによる不確定さの表現が必要と考えられ、現在モデルを検討している。

    researchmap

  • 遺伝性疾患のスクリーニングに向けた診療記録からの表現型の抽出と臨床応用評価

    研究課題/領域番号:20H04279  2020年04月 - 2023年03月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    河添 悦昌, 関 倫久, 篠原 恵美子

      詳細を見る

    配分額:18070000円 ( 直接経費:13900000円 、 間接経費:4170000円 )

    本研究は以下を研究目的とする。1) 表現型を抽出する基盤技術の開発:日本語で記録された診療テキストから表現型に関する情報を自然言語処理によって抽出し、既存の医学用語集に対応付けるための基盤技術となる症例報告テキストコーパスを開発する。2)遺伝性疾患のランキング精度評価:開発した基盤技術を用いて、症例報告や退院サマリから表現型を抽出し、既存アルゴリズムを用いた疾患のランキング精度を評価する。これまでに、厚生労働省の指定難病333疾患のうち151疾患について計362の症例報告テキストを収集し、約50種の固有表現タグと35の関係タグによって、表現型をアノテーションするための基準を開発した。この基準は、言語学的な制約よりもむしろ、医療の観点に立脚した情報モデルに基づくものであり、網羅性と一貫性を重視するように設計した。また、この基準によるアノテーションを実施し、362症例報告からなるコーパスと、固有表現抽出と関係抽出によってアノテーションを再現する機械学習モデルを開発した。
    本年度は、コーパスの質の改善を進めるとともに、テキスト再配布の許諾が得られた179症例報告(183症例)を含むコーパスをiCorpus(Corpus of clinical case reports of intractable diseases)と名付け研究者のHPで公開した。また、特定の固有表現タグと関係の組みで同定される表現型に対して、3種類の異なる病名用語集への対応付けの実施と、用語を自動でコーディングする手法の開発を進めた。更に、実診療テキストに対する適応性を評価するために、告示難病32症例の退院サマリに対しても同様のアノテーションを進めた。

    researchmap

  • 大規模臨床データを用いた機械学習による入院患者診療フローの診療補助モデルの開発

    2019年

    一般財団法人東京医学会  2019年度一般財団法人東京医学会医学研究助成 

    関倫久

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • ヒト心筋細胞移植療法実現へ向けた患者移植用iPS細胞株の樹立および選抜法の最適化

    2016年 - 2017年

    文部科学省  科学研究費補助金(若手研究(A)) 

    関倫久

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • RNAウイルスを用いたiPS細胞治療用の未分化細胞除去ワクチンの開発

    2016年

    文部科学省  科学研究費補助金(挑戦的萌芽) 

    福田恵一

      詳細を見る

    資金種別:競争的資金

    researchmap

  • 微量血液由来のiPS細胞を用いた先天性心臓イオンチャネル疾患の心筋細胞解析系確立

    研究課題/領域番号:11J30002  2011年 - 2013年

    日本学術振興会  特別研究員奨励費  特別研究員奨励費

    関倫久

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    微量血液由来のiPS細胞を用いて先天性心臓イオンチャネル疾患の心筋細胞解析系を確立するため、我々は微量血液から培養されたヒト末梢血T細胞より樹立されたiPS細胞の解析を行った。これらのiPS細胞がT細胞受容体の遺伝子構成を内包することをシークエンスにより遺伝子配列レベルで確認した。これらを心筋へ分化誘導し、表現型の解析を進めた。分化プロトコールは浮遊培養系を用い、浮遊培養開始から4日目まではWnt3aを作用させ、以降はWnt3aを除き浮遊培養を継続した。同様の分化の培養系がES細胞、レトロウイルスで作製した線維芽細胞由来iPS細胞で拍動胚様体を出現させることを確認した。それらの細胞と同様に、センダイウイルスで作成したT細胞由来iPS細胞の分化において、浮遊培養開始後10-15日目頃より拍動する胚様体が出現することを確認した。我々はさらにこのようにして得られた拍動する胚様体の解析を進めた。これらの胚様体内には機能的な心筋細胞が存在し、RNAレベルで心筋特異的マーカー(GATA4、Mef2c、ANP、αMHC、βMHC、MLC2a、MLC2v、MYH6、cTNNI)を発現していること、タンパクレベルでも同様に心筋特異的マーカー(Actinin、Nkx2.5、Troponin I、ANP)が発現していることをRTPCR, 免疫染色で確認した。また、これら拍動する胚様体をin-vitro多点電位記録システムであるMEAシステムのマルチ電極アレーディッシュに乗せると、1~2日で接着し、底面の電極で活動電位を記録することができた。この実験系を用いて各種抗不整脈薬(Na, Ca, Kチャネルブロッカー)に対する心筋細胞の応答性を解析した。T細胞由来の心筋細胞は遺伝子再構成を内包するため、その影響が危惧されたが、各種チャネルブロッカーに生理的な反応を示すことを確認した。さらに、これら心筋細胞は電子顕微鏡レベルで機能的心筋としての特徴を備えていることを確認した。以上の結果を論文として報告、また、皮膚由来のips細胞において先天性QT延症候群の患者由来のiPS細胞から作られた心筋細胞が、in vitroで病態の再現が可能であることを確認し、報告した。我々が確立した微量血液由来のiPS細胞が先天的心臓イオンチャネル疾患の心筋細胞の解析に応用可能である可能性が示された。

    researchmap

  • 先天性QT延長症候群の疾患特異的iPS細胞の樹立および実験系の構築

    研究課題/領域番号:22790725  2010年 - 2011年

    文部科学省  科学研究費補助金(若手研究(B))  若手研究(B)

    関倫久

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    我々はiPS細胞を臨床応用する際の障壁として、皮膚生検組織から作成するという点、樹立に数カ月を要するという点、腫瘍形成の危険があるという点が問題となっていることに注目した。特に皮膚生検では患者の体に跡が残るため、特に女性や幼児から作成する際に大きな障害となっていた。これらの問題を解決するべく、患者にとってより低侵襲に、短期間に、より安全なiPS細胞を樹立する方法を開発し、移植ソース、病態再現ツールとして臨床に適用可能なiPS細胞樹立法を確立することを目的とし研究を開始した。我々は臨床応用を見据えたiPS細胞の樹立へ向けて、採取細胞の検討を行った。外来で容易に採取可能で、患者の負担が最小限である組織採取法を検討した結果、我々は末梢血T細胞に注目した。末梢血T細胞は採血で採取が簡便に可能であり、患者の体に傷はほぼまったく残らない。さらに末梢血T細胞は抗CD3抗体、インターロイキン2(IL2)の存在下で容易に増殖させることが可能である。そこで我々はセンダイウイルスがヒト活性化末梢血T細胞に高効率で感染することに注目し、センダイウイルスを用いて4つの転写因子(Oct3/4,Sox2,Klf4,c-Myc)を導入し、末梢血T細胞からiPS細胞を樹立することに成功した。既に我々は、ヒトiPS細胞からの浮遊培養を用いた心筋誘導、および薬剤反応の評価の実験系の構築に成功している。今後、健常成人、先天性心臓イオンチャネル疾患の患者からiPS細胞を樹立し、心筋へ分化誘導し解析する。iPS細胞の樹立のための細胞採取を採血で行し、既に同樹立法により正常例4例、先天性QT延長症候群3例(LQT22例、LQT71例)からの樹立が終了しており、今後対象症例を増やしていく。

    researchmap

▼全件表示